Skip to Main Content

Pathology Grand Rounds Feb. 12, 2026 - Liron Pantanowitz, MD, PhD, MHA

February 20, 2026

Pathology Grand Rounds Feb. 12, 2026 - Liron Pantanowitz, MD, PhD, MHA, Maud Menton Professor and Chair, Department of Pathology, University of Pittsburgh, University of Pittsburgh Medical Center, on, "The Digital Pathology Journal at UPMC."

ID
13856

Transcript

  • 00:00Is my great pleasure,
  • 00:02to introduce our today's grand
  • 00:04round speaker, doctor
  • 00:06Liron Pantanovic.
  • 00:07Actually, Liron doesn't need any
  • 00:09introduction, but I'm going to
  • 00:10do it anyway.
  • 00:11So,
  • 00:14Liron is I'll just start.
  • 00:16He's the godfather of digital
  • 00:17pathology. He's the godfather of
  • 00:19AI in pathology, and it's
  • 00:21a real blast to have
  • 00:22him here. Thank you so
  • 00:23much for coming, Liron. And,
  • 00:25in terms of, like,
  • 00:28you know, his education and
  • 00:29everything, Liron actually is,
  • 00:31is started his undergraduate and
  • 00:33graduate studies
  • 00:35in South Africa where he
  • 00:36actually initially also practiced a
  • 00:38little bit. Then, he moved
  • 00:40to US in nineteen ninety
  • 00:41nine where he did his
  • 00:43residency
  • 00:44in APN CP at Tibet
  • 00:46Israel, so in the neighborhood
  • 00:48in up in Boston.
  • 00:50He, also did their hematopathology
  • 00:53fellowship
  • 00:54and followed by the cytopathology
  • 00:56fellowship in a Bay State,
  • 00:57medical center. As a pathologist,
  • 00:59he started his career first
  • 01:01as an instructor in a
  • 01:02Harvard system,
  • 01:04and then,
  • 01:05he moved to Tufts in
  • 01:06two thousand five, stayed there
  • 01:08for five years,
  • 01:10and then came to Pittsburgh
  • 01:12in two thousand
  • 01:13two thousand ten. I couldn't
  • 01:14believe it. It was two
  • 01:15thousand ten. So it was
  • 01:17really my great privilege to
  • 01:19know Liron at that time
  • 01:20and,
  • 01:22he's absolutely brilliant pathologist. He's
  • 01:26definitely independent thinker,
  • 01:28progressive thinker.
  • 01:31He
  • 01:32published
  • 01:33over you stopped your CV
  • 01:34in twenty twenty three, over
  • 01:35six hundred
  • 01:37manuscripts, book chapters, everything else,
  • 01:40numerous talks across the world,
  • 01:42and he's really the one
  • 01:44who actually paid the way
  • 01:45for the digital pathologist to
  • 01:47digital pathology. And he had
  • 01:49idea of how digital pathology
  • 01:51should work in a clinical
  • 01:53a clinical sense twenty twenty
  • 01:55five years ago, and it's
  • 01:57actually great to see that
  • 01:58this is coming now in
  • 01:59life. So I'll stop there,
  • 02:01Lerim, because I can go
  • 02:02forever about you, but thank
  • 02:04you so much. Thank you.
  • 02:12So good afternoon, everyone.
  • 02:15And thank you, doctor Dacek,
  • 02:16and thank you for inviting
  • 02:17me to be your grand
  • 02:18round speaker.
  • 02:20So in October of two
  • 02:21thousand and thirteen,
  • 02:24I was standing right here.
  • 02:26So doctor Morrow had invited
  • 02:28me for grand rounds back
  • 02:29in two thousand thirteen. And
  • 02:31guess what I was asked
  • 02:32to talk about? Digital pathology
  • 02:34at UPMC.
  • 02:35So I'm hoping in the
  • 02:36twelve plus years that I
  • 02:37can update,
  • 02:39whatever I spoke to you
  • 02:40about then. This is not
  • 02:41a just a rehash of
  • 02:42the same old PowerPoint.
  • 02:46Okay. That being said,
  • 02:48I do wanna let you
  • 02:49know,
  • 02:50I work a lot with
  • 02:51industry either on advisory boards,
  • 02:53consult with them. I have
  • 02:54these two startups which have
  • 02:55gone nowhere. In fact, they've
  • 02:57only cost me money.
  • 03:00But I wanted to disclose
  • 03:02that, and none of that
  • 03:02should really influence the contents
  • 03:04of this talk.
  • 03:06So my objective is pretty
  • 03:08simple.
  • 03:09There are three of them.
  • 03:10One,
  • 03:11I wanted to review with
  • 03:12you the evolution of digital
  • 03:13pathology at UPMC,
  • 03:15and you'll see it was
  • 03:16not an easy pathway. And
  • 03:17we are still on that
  • 03:19evolutionary
  • 03:20pathway because
  • 03:21when when people say we're
  • 03:22going digital or we're going
  • 03:23to start digital,
  • 03:25what the one thing they
  • 03:25don't realize is it's a
  • 03:27never ending pathway. It's like
  • 03:28when you buy your first
  • 03:29iPhone,
  • 03:30you know, next year there'll
  • 03:31be another version of an
  • 03:32iPhone, and you're going to
  • 03:33have to learn to use
  • 03:34it and so forth.
  • 03:36I do want to point
  • 03:37out that along this journey,
  • 03:39at UPMC, none of that
  • 03:40was easy. None of it
  • 03:41was perfect. We made a
  • 03:42lot of mistakes. And so
  • 03:43I know that you're on
  • 03:44a digital pathology journey of
  • 03:46your own. And so I'll
  • 03:47share some of our lessons,
  • 03:48and hopefully
  • 03:50they'll benefit you.
  • 03:51And finally,
  • 03:53everything we did, every camera
  • 03:55we purchased, ultimately helped build
  • 03:57the infrastructure,
  • 03:59helped get people more savvy,
  • 04:01and receptive to using technology,
  • 04:03and our own institution to
  • 04:05understanding that we need to
  • 04:06evolve and be flexible in
  • 04:08order to keep up with
  • 04:09the practice of medicine so
  • 04:10that we can have an
  • 04:11infrastructure in which we can
  • 04:12actually use artificial intelligence.
  • 04:17So my belief simply
  • 04:19with digitizing slides, and I'll
  • 04:21confine most of my talk
  • 04:22to anatomical pathology,
  • 04:25and a lot of that
  • 04:26to,
  • 04:27surgical pathology
  • 04:28because there's a lot that
  • 04:29can be said about lab
  • 04:31medicine
  • 04:32going digital too as well
  • 04:33as cytology,
  • 04:35is is the minute you
  • 04:36digitize your glass slide,
  • 04:38you gain the portability
  • 04:40and the applications you can
  • 04:41run on that. And I've
  • 04:43had many conversations
  • 04:45with some very serious famous
  • 04:46pathologists,
  • 04:48and I've told them simply
  • 04:49that, who have were very
  • 04:51resistant to going digital,
  • 04:54that the reason they have
  • 04:56their own mobile phone
  • 04:58is, one, that they don't
  • 05:00have to be in their
  • 05:01office to use their landline
  • 05:02to make a phone call
  • 05:03even though they know that
  • 05:05the phone call you'll make
  • 05:05in your office is way
  • 05:07more clear than using your
  • 05:08mobile phone, traveling, going through
  • 05:10a tunnel, but you you
  • 05:12still enjoy the portability.
  • 05:14But more than that is
  • 05:16all the apps you have
  • 05:17on you. Check your email,
  • 05:19use your GPS, now chat,
  • 05:20GPT, etcetera. And that would
  • 05:22not be possible
  • 05:24if you don't digitize your
  • 05:25slides.
  • 05:27So, as a chair, there
  • 05:28are several things that I
  • 05:30would like to accomplish in
  • 05:31my department,
  • 05:32and I think I've already
  • 05:33shared these with,
  • 05:35your chair. But the first
  • 05:37is medicine is a very
  • 05:38connected field. And, you know,
  • 05:40unless we're going to stay
  • 05:41in the basement with our
  • 05:42paperwork and microscopes forever, no
  • 05:44one will know us.
  • 05:45So I am trying to
  • 05:47consolidate everything where I am.
  • 05:49We're a forty plus hospital
  • 05:50system.
  • 05:52Pathologists are not all in
  • 05:53the same area. So if
  • 05:55I can consolidate that, in
  • 05:56fact, I have to consolidate
  • 05:57that. I just don't have
  • 05:58enough cytotechnologists
  • 06:00and histotechnologists
  • 06:02to put in labs
  • 06:03all over the place.
  • 06:05We definitely
  • 06:06need to need to be
  • 06:06efficient.
  • 06:07Someone's working from home. Someone
  • 06:09needs coverage.
  • 06:11The only way I can
  • 06:11really do that is with
  • 06:12telepathology.
  • 06:13The only way to reduce
  • 06:15turnaround time, majorly between hospitals,
  • 06:18is by using digital images.
  • 06:21And for me to have
  • 06:21someone pull an old slide,
  • 06:23if someone has a resection
  • 06:24or they're going to do
  • 06:25a frozen section, they would
  • 06:26love to see a prior
  • 06:27immediately within a minute, not
  • 06:29put in a request
  • 06:30that may never actually deliver
  • 06:32a slide to you is
  • 06:33to go digital.
  • 06:35Plus the distribution of the
  • 06:36workload. So we, in Pittsburgh,
  • 06:38have a very subspecialized
  • 06:40practice, a lot of, you
  • 06:41know, people in different areas.
  • 06:43And to support the subspecialization,
  • 06:45they need the cases sent
  • 06:46to them. And throughout our
  • 06:48system, the best way to
  • 06:49refer cases to them is
  • 06:51from community to do that
  • 06:52digitally these days.
  • 06:54And if you don't go
  • 06:55digital and you don't integrate,
  • 06:57you can forget about using
  • 06:59AI effectively.
  • 07:02Now the hospital and the
  • 07:03dean obviously want to know
  • 07:04from me, well, Iran, if
  • 07:05we give you all this
  • 07:06money to invest in technology,
  • 07:09where's the revenue? Where can
  • 07:10you make money out of
  • 07:12using the technology? Or how
  • 07:13are you going to save
  • 07:14costs? And, you know, that
  • 07:15is a difficult question,
  • 07:18to answer. But also importantly
  • 07:20is where's the quality that
  • 07:21you add? Is there a
  • 07:22value to doing this?
  • 07:24And, of course, lower liability.
  • 07:27It just takes one twenty
  • 07:28million dollars lawsuit that could
  • 07:30have been prevented using technology.
  • 07:32We learned that mistake back
  • 07:34in the barcoding era. There
  • 07:35was no money to be
  • 07:36made in barcoding all your
  • 07:38slides and your blocks. But,
  • 07:39if there was a mix
  • 07:40up of a case,
  • 07:42if you didn't barcode,
  • 07:44you know, that was well
  • 07:45worth the money spent.
  • 07:47We are in this era
  • 07:48of computational pathology, which is
  • 07:50AI.
  • 07:52And I think it's essential
  • 07:54for pathologists and trainees to
  • 07:55know how to create, validate,
  • 07:57and use AI.
  • 07:59Most people don't even know
  • 08:00how to monitor AI.
  • 08:02And there are lots of
  • 08:03companies who want to work
  • 08:04with
  • 08:06industry and academia to join
  • 08:08that partnership to advance technology.
  • 08:10They cannot do it on
  • 08:11their own. And frankly, the
  • 08:13way that federal funding and
  • 08:14everything else is going, it
  • 08:16makes a whole lot of
  • 08:17sense to work with industry
  • 08:18to try and get stuff
  • 08:19done.
  • 08:21Plus, the residents that apply
  • 08:23to our programs now, the
  • 08:25fellows that want to come
  • 08:26work at UPMC, and even
  • 08:27the junior faculty who
  • 08:30went to residency programs that
  • 08:31were fully digital do not
  • 08:32want to take jobs with
  • 08:33us unless we're fully digital.
  • 08:35And so there are many
  • 08:37residents that request to speak
  • 08:38to me because they want
  • 08:39to know my digital pathology
  • 08:41roadmap before they match and
  • 08:43rank us, believe it or
  • 08:44not.
  • 08:46And, of course, the reputation
  • 08:47of Pitt.
  • 08:49We want to be known
  • 08:49as a place in Pittsburgh
  • 08:50where we do cutting edge
  • 08:51technology. We do not wanna
  • 08:53be known as
  • 08:54a steel industry city like
  • 08:56we were fifty years ago.
  • 08:58Two, we want our clinicians
  • 09:00and our patients to know
  • 09:01that we can offer them
  • 09:03the latest and greatest cancer
  • 09:05diagnostics,
  • 09:06prognostics, etcetera.
  • 09:07So the next in vitro
  • 09:09diagnostic test that comes out,
  • 09:10and there are many that
  • 09:11pharma are working on, if
  • 09:12you can only do that
  • 09:14by scoring it with a
  • 09:16computer
  • 09:17because look at the mess
  • 09:18with PDL one, right, how
  • 09:20How we have to score
  • 09:21that manually and all the
  • 09:22different scoring systems. We wanna
  • 09:23be at the forefront of
  • 09:24that.
  • 09:26And people wanna come and
  • 09:27work with us. We opened
  • 09:28an AI center just over
  • 09:30a year ago,
  • 09:31and I get about
  • 09:33twenty
  • 09:34emails
  • 09:35every month from people wanting
  • 09:36to come and work
  • 09:38in our AI center with
  • 09:39us, etcetera. So we wanna
  • 09:40attract talent. Now here's the
  • 09:42reality, okay, which many of
  • 09:44you know. I'm not yet
  • 09:45to sell you your vacation
  • 09:47on the left, which is
  • 09:48what the postcard and the
  • 09:49flyer does, okay, because that's
  • 09:51what the digital pathology vendors
  • 09:53tell you.
  • 09:55Buy the system and install
  • 09:56it, and that's what life
  • 09:57will be like. Reality is
  • 09:58what it more like on
  • 09:59the right. When you arrive
  • 10:00at your
  • 10:01paradise beach vacation,
  • 10:04that's what digital pathology looks
  • 10:05like. Okay. It's messy and
  • 10:07it's difficult and, you know,
  • 10:08the IT systems aren't integrated
  • 10:10and things are more expensive
  • 10:11than you had anticipated. So
  • 10:13let me actually
  • 10:14give you a reality check
  • 10:15and not paint paradise for
  • 10:17you. So just a little
  • 10:18bit of what are we
  • 10:18talking about when one talks
  • 10:20about digital pathology workflow.
  • 10:22So the most important thing
  • 10:23about digital pathology, which hopefully
  • 10:25you'll get throughout this talk,
  • 10:27is the pre imaging part.
  • 10:28Before a slide even gets
  • 10:29onto a scanner,
  • 10:31if you haven't done certain
  • 10:32things, your digital pathology will
  • 10:34fail. But the pre imaging
  • 10:36side starts with scanning a
  • 10:38slide, and if you haven't
  • 10:39barcoded that slide, you can
  • 10:40forget about an automated system
  • 10:42that works well. And if
  • 10:43you don't have the perfect
  • 10:45barcode, believe it or not,
  • 10:47about ten
  • 10:48percent or more of those
  • 10:49slides will get scanned, but
  • 10:50they're going to cyberspace. They're
  • 10:52not going to get linked
  • 10:53to your LIS or wherever
  • 10:54you want. Okay. So you
  • 10:55really need good barcoding,
  • 10:57practices in place.
  • 10:59And then on the top,
  • 11:00as you can see, how
  • 11:01you're going to also scan
  • 11:03cytology, microbiology,
  • 11:05hematopathology,
  • 11:06and fluorescence images. For those,
  • 11:08you kind of need some
  • 11:10niche workflows and niche,
  • 11:12scanners. But once you've scanned
  • 11:14your slide,
  • 11:16you can store those
  • 11:17and ideally link it to
  • 11:19your lab information system. I've
  • 11:20always been a proponent of
  • 11:22practicing pathology with an LIS
  • 11:24driven workflow. Not that I
  • 11:26love the lab information system,
  • 11:27but that's where
  • 11:29our workflow goes through. That's
  • 11:31where we do reporting and
  • 11:32auditing.
  • 11:33That's,
  • 11:34you know, where billing happens.
  • 11:36And wherever billing happens, that's
  • 11:38where they want you to
  • 11:38work.
  • 11:40You can store it with
  • 11:41an enterprise. The The VNA
  • 11:43stands for a vendor neutral
  • 11:44archive. So if your institution
  • 11:46has an imaging strategy that
  • 11:48all images, radiology, pathology, all
  • 11:50other ologies will be stored
  • 11:51somewhere and either viewed
  • 11:54by everyone in practice or
  • 11:55at least stored and used
  • 11:57for research, you can do
  • 11:58that.
  • 11:59And then, of course, when
  • 12:00the image is available for
  • 12:01someone on a workstation,
  • 12:03all the applications are endless.
  • 12:05You can share it remotely.
  • 12:06That's telepathology.
  • 12:08You can make a diagnosis
  • 12:09of that image, which is
  • 12:11primary diagnosis, meaning you don't
  • 12:12need the glass slide anymore.
  • 12:14You can analyze the pixels,
  • 12:16quantitative image analysis or AI,
  • 12:19and then use it for
  • 12:20research, education, and so forth.
  • 12:22Okay. So this is the
  • 12:23evolution of how digital pathology
  • 12:25unfolded at UPMC in this
  • 12:27actual order.
  • 12:29One was virtual education, two
  • 12:32tumor boards, frozen section telepathology,
  • 12:35then teleconsultation.
  • 12:37Then we added telecytology for
  • 12:39the rapid on-site e dials
  • 12:40in cytology.
  • 12:42Then we went to primary
  • 12:43diagnosis.
  • 12:44Then we opened an image
  • 12:45analysis lab to do quantitative
  • 12:46image analysis.
  • 12:48And now we're using AI.
  • 12:49So I'll run through that
  • 12:50with you. The pictures I've
  • 12:52shown you are actual real
  • 12:53pictures from UPMC. We've been
  • 12:55through every kind of hardware,
  • 12:56software, camera, scanner,
  • 12:58homegrown,
  • 12:59commercial,
  • 13:00and so we've learned from
  • 13:02that. And not only have
  • 13:03we learned from that, but
  • 13:04our IT department has learned
  • 13:06from that. We have IT
  • 13:07analysts that have used all
  • 13:09of these instruments and are
  • 13:10very comfortable, you know, with
  • 13:12modern technology having gone through
  • 13:14this process with us.
  • 13:16So the first thing we
  • 13:17did was virtual education. Our
  • 13:19residents back in the day
  • 13:20wanted to look at slides
  • 13:21virtually. UPMC was unfortunately very
  • 13:24geographically dispersed. We had hospitals
  • 13:26all over Pittsburgh. Now residents
  • 13:28had to rotate and how
  • 13:29are they gonna do unknown
  • 13:30conferences and so on. So
  • 13:32they wanted a virtual
  • 13:35platform to do that. There
  • 13:36was nothing commercially available. So
  • 13:38and Neil Parwani and myself
  • 13:39back in the day working
  • 13:40with IT, we built our
  • 13:41own homegrown system.
  • 13:43I'll tell you that it's
  • 13:44better than any commercial system
  • 13:45out there today. Nevertheless,
  • 13:47UPMC didn't want us to
  • 13:49build. They wanted us to
  • 13:51buy. So we bought PathXL,
  • 13:53worked wonderfully. Then Philips bought
  • 13:54it and shut it down.
  • 13:56And now we use Path
  • 13:57Presenter.
  • 13:58But the picture I've shown
  • 13:59you there is a resident
  • 14:02who wanted to do a
  • 14:03one month elective with me
  • 14:04in Cytology.
  • 14:05And that, by the way,
  • 14:06is probably fifteen years ago.
  • 14:11You will notice, and I
  • 14:12took a picture as I
  • 14:12was walking by, she has
  • 14:14pushed the microscope off to
  • 14:15the side and she's looking
  • 14:17at all the cytology teaching
  • 14:18sets on a monitor. And
  • 14:20boy, that's a terrible monitor,
  • 14:21such low resolution. But she
  • 14:23spent the month going through
  • 14:24all our teaching sets because
  • 14:26she had a natural affinity
  • 14:27to doing it digitally.
  • 14:28Maybe that's why she became
  • 14:30a dermatopathologist
  • 14:31today. But, nevertheless,
  • 14:33that was our first foray
  • 14:34because the residents forced us
  • 14:36to go digital,
  • 14:37and they still do today.
  • 14:40The next was
  • 14:42our residents and fellows got
  • 14:43tired of running tumor boards
  • 14:45the old fashioned way, and
  • 14:46they were the ones that
  • 14:47pushed us.
  • 14:49That is Soumyk Roy.
  • 14:51He was a a resident
  • 14:52in our program. This is
  • 14:53his year when he did
  • 14:54his GU fellowship. Then he
  • 14:55became a molecular pathology,
  • 14:58guru, and now he's a
  • 14:59big deal at the University
  • 15:00of Cincinnati.
  • 15:02But what Soumyk did was
  • 15:03Soumyk was, you know, very
  • 15:05digitally savvy, liked to code
  • 15:06for a hobby on the
  • 15:07side, and he came to
  • 15:08me and said, Doctor. Bentano,
  • 15:09it's
  • 15:10the worst part of my
  • 15:11GU fellowship is every other
  • 15:13day I've got to go
  • 15:14and find the slides. I've
  • 15:15got to take photos and
  • 15:16put them in a PowerPoint
  • 15:17presentation.
  • 15:18And then I have to
  • 15:19show up at the tumor
  • 15:20boards.
  • 15:22And every time, you know,
  • 15:23if it's a different room,
  • 15:24I've got to figure out
  • 15:25how to plug in this
  • 15:25USB, and and, it's asking
  • 15:27me to reformat the drive.
  • 15:29And then the GU
  • 15:31surgeons, the urologists are asking
  • 15:33me questions that had nothing
  • 15:34to do with the pictures
  • 15:35I took, and I couldn't
  • 15:36show them.
  • 15:37So it was embarrassing. Whereas
  • 15:39the radiologist would just show
  • 15:40up
  • 15:41one minute before the a
  • 15:42coffee in hand, log on,
  • 15:43and they could see anything.
  • 15:44Go back. Look at the
  • 15:45CT, that CT. Like so
  • 15:46can can we go digital?
  • 15:48And so I said to
  • 15:49Soren, let's do it.
  • 15:51And so he used his
  • 15:52own iPad. All the GU
  • 15:54slides got scanned,
  • 15:56and he was fully prepared
  • 15:57for TumorBoard.
  • 15:59So today,
  • 16:00and I did this recent
  • 16:01calculation because UPMC asked me,
  • 16:03where's the return on investment
  • 16:04if we digitize all forty
  • 16:06of your hospitals?
  • 16:08So we run fifty TumorBoard
  • 16:10throughout our UPMC system.
  • 16:13Many hours are invested in
  • 16:14that. And we calculated that's
  • 16:16three FTEs a week to
  • 16:17run those tumor boards.
  • 16:20Now that most of those
  • 16:21are digital, not all, but
  • 16:22most of those are digital,
  • 16:23I'm saving three FTEs worth
  • 16:25of time and obviously administrators
  • 16:28like that. So
  • 16:31the next advantage of going
  • 16:32digital is that,
  • 16:34you can run your tumor
  • 16:35boards. And whether you scan
  • 16:36prospectively
  • 16:37or retrospectively, you still can
  • 16:39run your tumor boards.
  • 16:41Now, the number one application
  • 16:43for me is if you
  • 16:44go digital is that you
  • 16:45can share that image.
  • 16:47And I still think that's
  • 16:48the number one application even
  • 16:49more so than AI.
  • 16:51It's way easier to move
  • 16:52an image than to tell
  • 16:53a patient You can only
  • 16:55get your neurosurgery done at
  • 16:56this facility because that's where
  • 16:58we can do the frozen
  • 16:59sections,
  • 17:01or a particular procedure. And
  • 17:03it's so much easier and
  • 17:04actually less expensive to move
  • 17:06an image around them than
  • 17:08to have a pathologist move
  • 17:09around, to go do a
  • 17:10frozen or to go look
  • 17:11at a cytology touch grip
  • 17:12or imprint.
  • 17:14So in the acute setting,
  • 17:15you can do frozen sections
  • 17:17or wrap it on-site emails
  • 17:19for cytology digitally. Makes a
  • 17:21whole lot of sense.
  • 17:23If you have time,
  • 17:24you can send it to
  • 17:25someone to make a primary
  • 17:26diagnosis,
  • 17:27or you can receive a
  • 17:28consult. So that's
  • 17:30the advantage.
  • 17:32I often get calls,
  • 17:34even from Yale,
  • 17:36Like, which system should we
  • 17:37use? And that's for me,
  • 17:38like, which system are we
  • 17:39buying? And the problem is
  • 17:40we have so many systems
  • 17:41now that you can pick
  • 17:43live views, whole site imaging
  • 17:45views, etcetera.
  • 17:46And I simplify it as
  • 17:47this. So if you're attaching
  • 17:49something to your camera mean,
  • 17:51sorry, if you're attaching something
  • 17:51to your microscope or camera,
  • 17:53whether you're streaming a video
  • 17:54or taking a picture,
  • 17:56you need someone on the
  • 17:57other end who knows what
  • 17:58they're looking at, such a
  • 17:59technologist,
  • 18:00a pathologist, etcetera,
  • 18:03in order to practice telepathology.
  • 18:06But if you can scan
  • 18:07the whole slide without having
  • 18:08anyone skilled, just a PA,
  • 18:11maybe a resident in their
  • 18:12first year, or even someone
  • 18:14who's like a radiology,
  • 18:17assistant
  • 18:18who can just load the
  • 18:19slide for you,
  • 18:21then you can use robotic
  • 18:22or whole side imaging.
  • 18:24And and we've used and
  • 18:25are using all of these
  • 18:26different setups.
  • 18:29The first time we decided
  • 18:30to do frozen sections remotely
  • 18:31was,
  • 18:33in two thousand and one,
  • 18:35which is a long time
  • 18:36ago.
  • 18:37And
  • 18:38at some point, we had
  • 18:40no option
  • 18:41because
  • 18:42we were covering frozen sections
  • 18:45for transplants
  • 18:46in Italy.
  • 18:48Okay? So, our hospital was
  • 18:50supporting,
  • 18:52a hospital in Italy to
  • 18:53do bring up transplant and
  • 18:54do frozen sections. And they
  • 18:56didn't know even how to
  • 18:57interpret frozen sections for transplants.
  • 19:00We agreed to do that.
  • 19:01And so, we did it
  • 19:02by telepathology.
  • 19:03We're very dedicated transplant pathologists.
  • 19:05Dedicated, but difficult. Right, Sonya?
  • 19:07Yes. Okay. So, but they
  • 19:09would wake up at two
  • 19:10in the morning and do
  • 19:11frozen.
  • 19:12And, you know, through that
  • 19:13we learned. And then our
  • 19:14neuropathology
  • 19:14team followed suit, too.
  • 19:19So today,
  • 19:20we have these LV1
  • 19:23systems from Leica.
  • 19:25They're all around many hospitals.
  • 19:28Some are even located, you
  • 19:29will see, hundreds of miles
  • 19:31away where we do
  • 19:33tons of frozen sections a
  • 19:34day
  • 19:35remotely.
  • 19:36We were just being told
  • 19:38by Leica that they're no
  • 19:39longer going to support the
  • 19:40LV1, so we're looking at
  • 19:42new options to do frozen
  • 19:43sections,
  • 19:44digitally.
  • 19:46But what had happened over
  • 19:47time is concordance got better.
  • 19:49So in the beginning when
  • 19:51we were doing this ten,
  • 19:52twenty years ago,
  • 19:54our pathologists made mistakes. And
  • 19:56so concordance to the
  • 19:58permanent,
  • 19:59afterwards, now is way better.
  • 20:02Two, we don't
  • 20:03defer that many cases anymore.
  • 20:05In the beginning, they weren't
  • 20:06sure, so they would defer
  • 20:07to permanent. Now they hardly
  • 20:09defer cases.
  • 20:10But this is Pandora's box,
  • 20:12which is a downside. The
  • 20:13service got way busier.
  • 20:15Now that, for example, our
  • 20:16neurosurgeons know they can operate
  • 20:18in any hospital
  • 20:20and just like going to
  • 20:21a vending machine and pushing
  • 20:23and saying, I want a
  • 20:23soda right now, they can
  • 20:25do that. And so our
  • 20:27neuropathologists
  • 20:28are constantly barraged by frozen
  • 20:30sections
  • 20:31all the time every day.
  • 20:32They basically have to have
  • 20:34a neuropathologist
  • 20:34uncovering frozen
  • 20:36twenty four seven.
  • 20:37So that is a downside,
  • 20:39that, you know, and we've
  • 20:40enabled.
  • 20:42So this is, one hospital
  • 20:43today. You can see Shadyside
  • 20:45Hospital in this particular frozen
  • 20:47section room just so you
  • 20:47can see where we evolved
  • 20:49back in the day by
  • 20:50someone taking a picture in
  • 20:51Italy and sending it to
  • 20:52pathologists in Pittsburgh. Now we
  • 20:54have two of these instruments
  • 20:56in the frozen section room.
  • 20:57One is for neuropathology because
  • 20:59it's so busy.
  • 21:00One is for all the
  • 21:01other surgical pathology systems. Everyone's
  • 21:04trained. We can have a
  • 21:04first year resident who knows
  • 21:06what to do after hours,
  • 21:08validated, and it really works
  • 21:10well and it's streamlined. And
  • 21:11it's become common practice.
  • 21:13No one sort of
  • 21:14questions that, well, how are
  • 21:16we doing it? Or, wow,
  • 21:16this is modern technology.
  • 21:18It's as like, we wouldn't
  • 21:19have a frozen section room
  • 21:22without a microtome. We wouldn't
  • 21:23have a frozen section without
  • 21:24the ability to telepathology.
  • 21:29But what we did learn
  • 21:31and what did happen is
  • 21:32our surgeons missed us, believe
  • 21:34it or not.
  • 21:35I was just we didn't
  • 21:36miss them, but
  • 21:39but they missed us being
  • 21:40there in the frozen section
  • 21:41room.
  • 21:43They liked to walk in
  • 21:44there,
  • 21:45chat, harass us,
  • 21:47question the diagnosis, or whatever.
  • 21:49They liked us being there
  • 21:50physically present, and now they
  • 21:52were not.
  • 21:53So we were not there.
  • 21:55And so
  • 21:57that they wanted to still
  • 21:58see the case. They wanted
  • 21:59to talk to the pathologist.
  • 22:01And so not all of
  • 22:02them, but the neurosurgeon certainly
  • 22:03did. So it was very
  • 22:05simple.
  • 22:06Here's an example at Children's
  • 22:07Hospital where we have a
  • 22:08pediatric neuropathologist on the bottom
  • 22:10right with desktop screening software.
  • 22:13We made
  • 22:14monitors available in the OR.
  • 22:16And that's doctor Wiley before
  • 22:18he retired, our neuropathologist.
  • 22:20So now the surgeons feel
  • 22:22that they're still part of
  • 22:23the action. They can see
  • 22:24the case, talk to the
  • 22:25person, just not in person.
  • 22:30And because word got out
  • 22:32and our neuropathologists
  • 22:33were pretty good at doing
  • 22:35frozen sections remotely,
  • 22:37we got requests from outside
  • 22:39of UPMC.
  • 22:40And we've agreed to do
  • 22:41that. We don't want to
  • 22:42do too many because, as
  • 22:43I've said, we've opened Pandora's
  • 22:44box, and they're so busy
  • 22:45now.
  • 22:46And the hospital will not
  • 22:47allow me to have too
  • 22:49many neuropathologists.
  • 22:50They already think I have
  • 22:51too many neuropathologists.
  • 22:52But now Merripath, for example,
  • 22:54which is three hundred and
  • 22:55seventy miles away in Indianapolis,
  • 22:57we do their Frozen for
  • 22:58them too.
  • 22:59And why would I do
  • 23:00that? Well,
  • 23:02we don't make that much
  • 23:03money through frozen sections. But
  • 23:05what happens is now that
  • 23:06we have a relationship with
  • 23:07this group, we do their
  • 23:08frozen.
  • 23:09They send us many of
  • 23:10their permanent cases. They send
  • 23:11all their molecular testing to
  • 23:13us, and we have a
  • 23:13very good relationship. So we're
  • 23:15their choice of lab to
  • 23:16do all their work.
  • 23:18And it's not easy, just
  • 23:20so that you know, because
  • 23:22now my pathologists
  • 23:24need a license
  • 23:26in a different state. They
  • 23:27need to maintain that CME
  • 23:28in that state. They need
  • 23:30hospital privileges in a different
  • 23:31hospital system. And so there
  • 23:33are a lot of nuances.
  • 23:35And, boy, you do not
  • 23:36want to make a mistake
  • 23:36when it comes to regulations.
  • 23:38There was a lawsuit,
  • 23:40just FYI, did not happen
  • 23:42at UPMC, where a pathologist
  • 23:44made a misdiagnosis
  • 23:46called some something melanoma when
  • 23:48it was a Spitz Nevis.
  • 23:50And the reason the case,
  • 23:52I mean, the pathologist lost
  • 23:53the case was not because
  • 23:54of the misdiagnosis,
  • 23:56was the fact that they
  • 23:57did not hold a medical
  • 23:58license in the state where
  • 24:00the the slide was scanned.
  • 24:01Okay. So on that technicality,
  • 24:05you cannot practice medicine if
  • 24:07you don't have a license
  • 24:08in that state.
  • 24:09Now through the years, we've
  • 24:10learned a lot of things,
  • 24:11and I could stand here
  • 24:12for another hour and give
  • 24:14you lots of vignettes
  • 24:16of how things were difficult
  • 24:18and how things didn't work
  • 24:19out that well. But I'm
  • 24:20only going to share one
  • 24:21vignette with you. Okay?
  • 24:25And the scenario goes as
  • 24:26follows. So why I'm telling
  • 24:27you this is because you
  • 24:29really need to use this.
  • 24:31You're not gonna
  • 24:32get this kind of experience
  • 24:34through any book, through any
  • 24:35vendor, or just having a
  • 24:36quick conversation with someone at
  • 24:38a peer institution.
  • 24:39You really need to get
  • 24:40the technology and use it,
  • 24:42and you, you know, you
  • 24:43will learn and people will
  • 24:44become comfortable. And, unfortunately, you
  • 24:46will learn from mistakes. So
  • 24:47here's an example.
  • 24:49We had an instructor
  • 24:50at this particular hospital, and
  • 24:52he was asked to do
  • 24:53a frozen section on a
  • 24:54Whipple for the margin.
  • 24:56And there's the frozen section
  • 24:57on the top. And he
  • 24:59thought that's atypical. So he
  • 25:00told
  • 25:01the whipple surgeon,
  • 25:04big deal whipple surgeon, okay,
  • 25:06that it's atypical.
  • 25:07And, of course,
  • 25:08being a junior faculty,
  • 25:10the surgeon said,
  • 25:12I want a second opinion.
  • 25:14And I don't just want
  • 25:15anyone. I want the head
  • 25:16of GI at UPMC.
  • 25:18So, of course, we had
  • 25:19to page the head of
  • 25:20GI at a different hospital.
  • 25:21We had to find her.
  • 25:23We had to get her
  • 25:24her to log on to
  • 25:25her computer, and she didn't
  • 25:25really know. Okay. Show me
  • 25:27how do I log on
  • 25:27and how do I look
  • 25:28at it. And so she
  • 25:29looked at the case and
  • 25:30she said, I'm going to
  • 25:31call that negative. Well, it
  • 25:33came out permanent, which is
  • 25:34there, positive for cancer.
  • 25:37And, you know, that's not
  • 25:39a good scenario.
  • 25:40And it's not the technology's
  • 25:42fault. But the point here
  • 25:43is that you cannot just
  • 25:45expect to ask people to
  • 25:46use technology. And even if
  • 25:48you validate it,
  • 25:50you know, it's validated
  • 25:51so that the CAP
  • 25:53says it's safe. But you
  • 25:55really need to make sure
  • 25:56that people are competent, trained,
  • 25:58and ongoing competency and monitor
  • 26:00them. And so our neuropathologists,
  • 26:02for example, are very good.
  • 26:03They monitor
  • 26:04concordance rates, deferral rates every
  • 26:06month. They check with faculty.
  • 26:08So if one of the
  • 26:08faculty's deferral rate is too
  • 26:10high, then
  • 26:12doctor Julia Koffler, head of
  • 26:13neuropathology, will have a conversation.
  • 26:15Why are you deferring everything?
  • 26:16Or why is, you know,
  • 26:17your,
  • 26:18frozen versus final, you know,
  • 26:20out of whack compared to
  • 26:21everyone else?
  • 26:22So it needs to be
  • 26:23part of your QA.
  • 26:26Well, the next thing that
  • 26:27happened was,
  • 26:29well, you know, UPMC said,
  • 26:30well, if we can share
  • 26:31images, we should allow other
  • 26:32people outside the system to
  • 26:34send images to us for
  • 26:35a second opinion.
  • 26:37And, well, we decided to
  • 26:39get into the consultation business.
  • 26:42Wasn't my choice. Doctor Sam
  • 26:44Musen, the executive vice chair,
  • 26:45instructed me. Leron, you need
  • 26:47to build this system. Because
  • 26:49there wasn't anything we could
  • 26:50buy back in the day.
  • 26:51You know, now we have
  • 26:51Path Presenter, Choristo, many tools,
  • 26:53but there weren't many.
  • 26:55So we built this IT
  • 26:56system, And I'll tell you
  • 26:57that we customized it for
  • 26:59ourselves.
  • 27:00And you guys know, Peter
  • 27:01and John, customizing, you can
  • 27:02get things to work perfectly
  • 27:04for you, your your institution.
  • 27:06And we had the world's
  • 27:07best telepathology
  • 27:08system, I believe, and still
  • 27:10believe even though I've seen
  • 27:11many others, that worked very
  • 27:13well. And we received consultations,
  • 27:15and the vast majority of
  • 27:16our consultations came from China.
  • 27:18There was a reference lab
  • 27:19in China called KingMed,
  • 27:21and they sent us ten
  • 27:22thousand or more images a
  • 27:23year.
  • 27:24And they paid very well.
  • 27:25We had a contract basis.
  • 27:27And we paid the pathologists
  • 27:29to do the work.
  • 27:30But a couple of things
  • 27:32about that. So one, yeah,
  • 27:34you get really cool cases,
  • 27:36rare cases, academically very challenging.
  • 27:40But from an IT perspective,
  • 27:41it's a pain in the
  • 27:42butt.
  • 27:43Okay? Because, you know, you
  • 27:44need IT people to support
  • 27:45this. Our IT people did
  • 27:47not know how to speak,
  • 27:48you know, Mandarin or Chinese,
  • 27:49and all the servers were
  • 27:50in Chinese.
  • 27:52They had to work at
  • 27:53different hours. So if we
  • 27:53needed to connect something, make
  • 27:55sure that their system was
  • 27:56barcoded, I needed my IT
  • 27:58analyst to wake up at
  • 27:58four in the morning to
  • 27:59meet with theirs. And you
  • 28:00can imagine how well that
  • 28:01went down.
  • 28:03Culturally,
  • 28:04very different the way we
  • 28:05practice pathology and they practice
  • 28:07pathology.
  • 28:09Also, this reference lab, the
  • 28:10main one, received
  • 28:12samples from about nine hundred
  • 28:14labs throughout China, small rural
  • 28:16labs. And you can imagine
  • 28:17how good their histology was.
  • 28:19It was awful. And so
  • 28:21people would call and complain
  • 28:22to me, Leeron, the image
  • 28:23is awful. Had nothing to
  • 28:24do with the image. It
  • 28:25was the slide site. Right?
  • 28:26It was cut so thick
  • 28:27and full of tissue folds
  • 28:28and air bubbles and fingerprints.
  • 28:30And I've so I never
  • 28:31read many of those cases.
  • 28:33Had nothing to do with
  • 28:34the image.
  • 28:35And so we we slowly
  • 28:36had to get them to
  • 28:37improve all the pre imaging
  • 28:39factors.
  • 28:41You know, it worked very
  • 28:42well. But people ask me,
  • 28:45and eventually
  • 28:46politics killed that. So, So,
  • 28:48for example, we cannot do
  • 28:49business with China. They contact
  • 28:51us and say we do
  • 28:52not want to do business
  • 28:52with the US for political
  • 28:54reasons,
  • 28:55and and we don't do
  • 28:56that,
  • 28:57that many cases. Now we
  • 28:58can still get cases if
  • 29:00people want to send them
  • 29:00to me for teleconsultation
  • 29:02work, But it's not a
  • 29:03very
  • 29:04viable
  • 29:05business because it is very
  • 29:07demanding from an IT perspective
  • 29:09and even from a pathology
  • 29:10perspective. So even if a
  • 29:12pathologist is getting paid, say,
  • 29:13forty five or fifty bucks,
  • 29:15it takes hours to do
  • 29:16some of these cases.
  • 29:18They're very
  • 29:19hard. You know, when a
  • 29:19textbook says you get this
  • 29:21you'll see this one in,
  • 29:22you know, a hundred million.
  • 29:23Well, we got one of
  • 29:24those a week. Right? Because
  • 29:26there were many such difficult
  • 29:27cases that filtered our way,
  • 29:29and it took hours and
  • 29:30hours to do, and you
  • 29:30had to consult
  • 29:32a friend, and then you
  • 29:33felt bad that I'm getting
  • 29:34the forty five dollars and
  • 29:35you're not, etcetera. So it's
  • 29:37not really
  • 29:38the best revenue generator.
  • 29:40But then eventually what happened
  • 29:41at UPC was I got
  • 29:43contacted from people all around
  • 29:44the world, from from Chile,
  • 29:46Tibet.
  • 29:47We know you guys do
  • 29:48teleconsultation.
  • 29:49We see it on your
  • 29:50website, but we don't own
  • 29:51a scanner because we can't
  • 29:53afford it, but we still
  • 29:54want to send you digital
  • 29:55consults.
  • 29:56And so how do we
  • 29:57do that? And so at
  • 29:58that time, if many of
  • 29:59you remember, there were all
  • 30:00these adapters that you could
  • 30:01attach to your microscope, and
  • 30:02you could put your smartphone
  • 30:04on and take pictures.
  • 30:06And so,
  • 30:08we built this pocket pathologist
  • 30:10so people could take pictures
  • 30:12and upload it.
  • 30:14The app is still available
  • 30:15on the iTunes Store, but
  • 30:17we do not support this
  • 30:18because it became so demanding.
  • 30:20And, again,
  • 30:22if you wanna do this
  • 30:24from a charitable point of
  • 30:25view, makes a whole lot
  • 30:26of sense. But if you
  • 30:27wanna do this from a
  • 30:28profitable
  • 30:29profitable point of view and
  • 30:30generate generate revenue, there's no
  • 30:32way there's no way that
  • 30:34a poor pathology lab in
  • 30:36Tibet can afford US prices.
  • 30:39And so when they, you
  • 30:39know, found out how much
  • 30:40we're going to charge for
  • 30:41a consultation,
  • 30:42like, they couldn't afford that.
  • 30:44Alright?
  • 30:45So many times we would
  • 30:46just do it gratis.
  • 30:49And it it also drove
  • 30:51my IT people crazy, which
  • 30:52is why I ended it.
  • 30:53They got called all the
  • 30:54time for help. How do
  • 30:56I load this? How do
  • 30:57I attach the camera? My
  • 30:58adapter's falling. I can't focus.
  • 31:00All of those kind of
  • 31:00questions. It's just it was
  • 31:02fun and gimmicky, but it
  • 31:03doesn't really generate revenue.
  • 31:05But I remember a really
  • 31:06funny story is,
  • 31:08one of our GI pathologists
  • 31:09got twenty images sent to
  • 31:11them.
  • 31:13GI pathologist at Presbyterian Hospital.
  • 31:15And it was because the
  • 31:16person had a pancreatic neoplasm,
  • 31:17and they weren't sure if
  • 31:18it was adenocarcinoma
  • 31:19or a neuroendocrine tumor or
  • 31:21some combined tumor. It was
  • 31:22just very confusing.
  • 31:23And so they uploaded the
  • 31:24images.
  • 31:25But more than half the
  • 31:26images
  • 31:27were selfies because the pathologist
  • 31:29had the camera facing the
  • 31:30wrong way around.
  • 31:32Right? So, you know, there
  • 31:34was
  • 31:35it's just it was just
  • 31:36a huge headache. Nevertheless, we
  • 31:37learned a lot from that.
  • 31:38So what did we learn
  • 31:39from our teleconsultation
  • 31:43business? That there are not
  • 31:45enough pathologists in the world,
  • 31:46and there are certainly not
  • 31:47enough expert subspecialized pathologists around
  • 31:50the world. So if you
  • 31:51wanna do this,
  • 31:53you know, yes. People are
  • 31:54desperate for help. But can
  • 31:56they afford it? I don't
  • 31:57know. You have to figure
  • 31:58out a good deal with
  • 31:59someone who will pay you,
  • 32:00like, per capita
  • 32:02or or contracted amount. But
  • 32:03by case, I'm not so
  • 32:04sure that makes a whole
  • 32:05lot of, you know, money
  • 32:06for you. But do you
  • 32:08change patients' lives? Absolutely. What
  • 32:10we found was in the
  • 32:12beginning, the cases that were
  • 32:13sent to us from were
  • 32:14from pathologist to pathologist.
  • 32:15So the pathologist was sending
  • 32:17them to us. But then
  • 32:17word got out because we
  • 32:18made some major radical
  • 32:20diagnosis that changed people's lives.
  • 32:23I remember a case that
  • 32:24came in as a sarcoma,
  • 32:26and this patient was scheduled
  • 32:27for an amputation.
  • 32:28And and we did an
  • 32:30AFB stain, and that's all
  • 32:32it was. It was a
  • 32:32mycobacterial spindle cell neoplasm.
  • 32:34The patient just needed antibiotics
  • 32:36for TB,
  • 32:38not an amputation. And so
  • 32:39eventually, clinicians
  • 32:41realized that, wow, sending cases
  • 32:42to UPMC in America,
  • 32:44you know, is important when
  • 32:46stakes are high. So then
  • 32:47the clinicians asked for
  • 32:49consults to get sent to
  • 32:50us and eventually patients. Patients
  • 32:53overseas were prepared to pay
  • 32:54out of pocket to get
  • 32:55a second opinion. And so,
  • 32:57yes, it does work. But
  • 32:58what the pathology
  • 33:00clients valued most was not
  • 33:01our diagnosis, but our education.
  • 33:03The fact that we taught
  • 33:03them about stuff. And our
  • 33:04pathologists were generous in that
  • 33:06they sent an article or
  • 33:07they gave one or two
  • 33:08references,
  • 33:09about these novel entities and
  • 33:10so forth.
  • 33:11But required a huge commitment,
  • 33:13big IT lift, lots of
  • 33:15challenges, especially cultural. And I'll
  • 33:17tell you because a lot
  • 33:18of people ask me, we
  • 33:19want to get into the
  • 33:20consultation business.
  • 33:23How do we get these
  • 33:23digital slides? And it's much
  • 33:25harder than that because here's
  • 33:26a typical example. People want
  • 33:28to send you a small
  • 33:29round blue cell tumor. If
  • 33:30they send you the digital
  • 33:31slides, all you're gonna be
  • 33:32able to tell them is
  • 33:33it's a small round blue
  • 33:34cell tumor.
  • 33:35You're gonna need the tissue
  • 33:36to run FISH or immunos,
  • 33:39you know.
  • 33:40Are you gonna look
  • 33:42for, you know, subtle signs
  • 33:44that this is a lymphoma
  • 33:46and be sure, are you
  • 33:47gonna commit a hundred percent
  • 33:48on an HNE that this
  • 33:49is Ewing's sarcoma and not
  • 33:51do a follow-up EWS r
  • 33:52one study?
  • 33:54So
  • 33:55from that point of view,
  • 33:56they are not sending you
  • 33:57tubular adenomas and basal cell
  • 33:59carcinomas. They're sending you stuff
  • 34:01that you know today is
  • 34:02challenging or requires ancillary studies.
  • 34:04How did we address that
  • 34:05at UPMC?
  • 34:06Well, what we told these
  • 34:08labs sending to us, for
  • 34:09example, in China is you
  • 34:10need to up your game.
  • 34:12Because if you're gonna send
  • 34:13us certain,
  • 34:15you know, specimens that we
  • 34:16need we need ancillary studies
  • 34:18on, and you cannot send
  • 34:19us the tissue, for example,
  • 34:20in China, they're not allowed
  • 34:22to send the tissue, neither
  • 34:23data over to us, then
  • 34:25we need to make sure
  • 34:25that your flow lab, fish
  • 34:27lab, immuno lab has all
  • 34:28of these stains.
  • 34:30We even had their technologists
  • 34:32come spend a month with
  • 34:33us, train them, take our
  • 34:35SOPs and procedures, go back
  • 34:36and get them up and
  • 34:37running, help them validate it.
  • 34:39So when we wanted to
  • 34:40run ancillary studies, we told
  • 34:41them what to run, and
  • 34:42they would run. We didn't
  • 34:43get any of the revenue
  • 34:45from it, but
  • 34:46we maintained that teleconsultation
  • 34:48business. Alright. That being said,
  • 34:52I was a practicing side
  • 34:53up pathologist, and I did
  • 34:55not like the fact that
  • 34:56I had to run around
  • 34:57all over the hospital doing
  • 34:58on-site evaluations,
  • 34:59especially if I had to
  • 35:00leave the building,
  • 35:01and neither did my colleague
  • 35:03Doctor. Sarah Monaco. We're like,
  • 35:04what the heck? We're running
  • 35:05to fifteen places in a
  • 35:07day, and then we've got
  • 35:07to get back, and then
  • 35:08I've got a huge pile
  • 35:09of slides. I've still got
  • 35:10to sign out.
  • 35:12And she said to me,
  • 35:13you're the digital pathology guy.
  • 35:14Figure it out. So
  • 35:16at that point, no one
  • 35:17was really doing telesitology.
  • 35:19So we decided I decided
  • 35:20then, you know what? Wherever
  • 35:22we got cam wherever we
  • 35:22got microscopes, I'm putting cameras
  • 35:24on them, and we're streaming
  • 35:25them. And I'm training all
  • 35:26the
  • 35:27cytologists, cytotechnologists
  • 35:28how
  • 35:29to stream images to us.
  • 35:32And it makes total sense.
  • 35:33So
  • 35:34now we have
  • 35:36twenty sites
  • 35:37that I do telesitology.
  • 35:39I still practice and do
  • 35:41cytology service.
  • 35:43I have four computer monitors,
  • 35:44believe it or not.
  • 35:46Told yours your your faculty
  • 35:47you need more monitors, and
  • 35:49I can do three on-site
  • 35:50evaluations simultaneously at the same
  • 35:52time.
  • 35:53Yes. I multitask,
  • 35:54super crazy, but I don't
  • 35:55have to leave my office.
  • 35:56I'm way more efficient.
  • 35:58But the one thing that
  • 35:59did happen was and and
  • 36:00you need to know about
  • 36:02this because as you go
  • 36:03digital,
  • 36:04your system is gonna tell
  • 36:05you you need less and
  • 36:06less pathologists.
  • 36:08So what happened here is
  • 36:10we got so busy that
  • 36:11I requested,
  • 36:13through hospital leadership that we
  • 36:15need one or two more
  • 36:16side of pathologists
  • 36:17because we cannot cope with
  • 36:18all the work.
  • 36:21Then at the same time,
  • 36:22I asked them to pay
  • 36:23for the technology and put
  • 36:24it in. And then when
  • 36:25we got the technology and
  • 36:26we were efficient, and they
  • 36:27said, oh, you're publishing papers,
  • 36:29and this is is we
  • 36:30see how efficient you are
  • 36:31and how you get all
  • 36:31the work done. I was
  • 36:33never allowed to hire the
  • 36:34pathologists.
  • 36:35Okay? Because the cameras
  • 36:37replaced the pathologists,
  • 36:38which is true. So I
  • 36:39just want you to know,
  • 36:41Angelique, that scanner in your
  • 36:42office may be replacing a
  • 36:44pathologist. I don't know. But
  • 36:45at UPMC, the cameras did
  • 36:46replace pathologists.
  • 36:48Okay.
  • 36:50So let's
  • 36:52we then moved into whole
  • 36:53site imaging at UPMC. Okay.
  • 36:54And so currently, how do
  • 36:56we handle whole site images?
  • 36:57So I've shown you, yeah,
  • 36:59sort of the way we
  • 37:00deploy it. So let's start
  • 37:01at the bottom.
  • 37:02So we have scanners in
  • 37:03our institution connected to our
  • 37:05own Internet safe and secure
  • 37:07behind our firewall, and those
  • 37:08images are linked to the
  • 37:09lab information system.
  • 37:11That's a little,
  • 37:13pile of circles there. So
  • 37:15those are all linked. So
  • 37:16those are live images in
  • 37:17the LIS, and we can
  • 37:19use those for primary diagnosis,
  • 37:20tumor board, whatever we want.
  • 37:22But we also scan a
  • 37:23lot of slides,
  • 37:25and we don't link all
  • 37:26of those to the,
  • 37:27to the LIS,
  • 37:28and we use those for
  • 37:29many other things:
  • 37:31teaching, education, and so forth.
  • 37:33We are able to accept
  • 37:34wholesale images outside the system.
  • 37:37I do that less and
  • 37:38less now because of our
  • 37:39experience through teleconsultation.
  • 37:41It's not that profitable, and
  • 37:42it's a big IT lift.
  • 37:44But we are willing to
  • 37:45do that, and I often
  • 37:46do that if someone's asking
  • 37:47as a favor. We have
  • 37:48someone, they're desperate for a
  • 37:50diagnosis. They know that we
  • 37:51you have an expert at
  • 37:52UPMC. Please, can they look
  • 37:54at the case? Fine. We'll
  • 37:55do that for you.
  • 37:56We allow our pathologists to
  • 37:58sign out remotely.
  • 37:59So
  • 38:00am I allowed to let
  • 38:01people? USCAP is coming up.
  • 38:03I know that many of
  • 38:03our faculty will be there.
  • 38:05Our system is validated for
  • 38:06primary diagnosis. Can they sign
  • 38:08out from their hotel room
  • 38:09with the laptop?
  • 38:10Yes.
  • 38:12Can people work from home?
  • 38:14Yes.
  • 38:15And we do upload some
  • 38:16of our images to the
  • 38:17cloud. That's for AI analysis
  • 38:19because some of the vendors
  • 38:20that we contract with require
  • 38:22the the AI to be
  • 38:23run-in their environment, not our
  • 38:26environment. And so, you know,
  • 38:27that's
  • 38:29not easy, but we do
  • 38:30that. So that's kind of
  • 38:31the topology of how how
  • 38:33wholesale images do move around
  • 38:34the
  • 38:35system. Now
  • 38:37about ten years ago, UPMC
  • 38:39and GE went into business,
  • 38:40and they started this digital
  • 38:42pathology company called Omnix.
  • 38:45And UPMC did this study,
  • 38:47which was published,
  • 38:48and they convinced themselves that
  • 38:51if they install the Omnix
  • 38:53digital pathology system,
  • 38:55the whole sign imaging, and
  • 38:56they roll it out over
  • 38:57five years,
  • 38:58and And they look at
  • 38:59how will the system benefit
  • 39:00from it, how much does
  • 39:01it cost. And they actually
  • 39:02went, and they looked at
  • 39:03all the lawsuits UPMC had.
  • 39:06They looked at one or
  • 39:07two lawsuits.
  • 39:08And who signed it out?
  • 39:09Was it a generalist, or
  • 39:10was was it a specialist?
  • 39:12Like, did a dermatopathologist sign
  • 39:14out the melanoma, or was
  • 39:15it a general pathologist in
  • 39:16a community hospital?
  • 39:17They extrapolated that to the
  • 39:18top ten cancers, and how
  • 39:20much would that cost the
  • 39:21system? And so they they
  • 39:23that seventeen point that seventeen
  • 39:25point seven million dollars is
  • 39:26how much UPMC would save.
  • 39:28That was their calculation. And
  • 39:29based on that, they said,
  • 39:31and I was there at
  • 39:31the time doing informatics,
  • 39:33Leron, your job is to
  • 39:34implement this Omnic system and
  • 39:36everyone has to do primary
  • 39:37diagnosis.
  • 39:39They didn't tell me that
  • 39:41everyone who works at GPMC
  • 39:42is gonna hate me and
  • 39:43not wanna do it.
  • 39:45Right? But that was what
  • 39:46happened back in the day.
  • 39:47The histology lab didn't want
  • 39:49me bringing in these scanners,
  • 39:50taking up space.
  • 39:51The IT people were like,
  • 39:53we know nothing about digital
  • 39:54pathology. Like,
  • 39:55why are we doing this?
  • 39:57The pathologists
  • 39:58did not like it either.
  • 40:00Right? So that was it.
  • 40:01I even had one pathologist
  • 40:03who did his own time
  • 40:04and motion study.
  • 40:07He was a breast pathologist.
  • 40:09He's a very famous breast
  • 40:10pathologist today. But the breast
  • 40:11pathologists, as you know, always
  • 40:12say that they have the
  • 40:13most slides per case. But
  • 40:14that's because it's their own
  • 40:15fault. They take so many
  • 40:17sections per case.
  • 40:21But he he proved that
  • 40:23if he did his daily
  • 40:25work with a microscope and
  • 40:26glass slides, he was way
  • 40:28more efficient
  • 40:30than if he did it
  • 40:31digitally.
  • 40:32In fact, he was twenty
  • 40:33five percent quicker.
  • 40:35And he asked to have
  • 40:35an appointment with me, him,
  • 40:37and the chair of about
  • 40:38Apartment at the time, and
  • 40:39we met.
  • 40:40And, I said, that's true,
  • 40:42actually. Pathologists are very quick,
  • 40:43especially very experienced, you know,
  • 40:45getting that slide to move
  • 40:46over the stage with a
  • 40:47microscope.
  • 40:47But then I asked him,
  • 40:49did you take into account
  • 40:51how long it takes the
  • 40:53if we're counting turnaround time
  • 40:54to get the case out,
  • 40:55how long it takes from
  • 40:56the histology lab
  • 40:58to get you that slot
  • 41:00if you add that in
  • 41:01versus it was available immediately
  • 41:03digits?
  • 41:04And, of course, the minute
  • 41:06he saw
  • 41:07the turnaround time, not from
  • 41:09his perspective,
  • 41:10but from the lab's perspective,
  • 41:11that the throughput,
  • 41:13okay, that was obviously a
  • 41:15deal breaker. So he realized
  • 41:16that
  • 41:17that doesn't make a lot
  • 41:18of sense. And today, he
  • 41:20keeps asking me, when are
  • 41:21we getting more scanners? When
  • 41:22are we getting more scans?
  • 41:23Okay. That same pathologist.
  • 41:26Okay. Lab also figured out
  • 41:28that if we go slide
  • 41:29less, basically,
  • 41:30it would be way more
  • 41:31lean and efficient because the
  • 41:32spaghetti maps of, you know,
  • 41:33making slides, taking them off
  • 41:35to the immuno, bringing them
  • 41:36back,
  • 41:37etcetera,
  • 41:38takes forever.
  • 41:40You can imagine now it's
  • 41:41even worse because we have
  • 41:42less histotech. It's very hard
  • 41:43to find histotechs,
  • 41:45to staff all the labs,
  • 41:46but we would be more
  • 41:48efficient.
  • 41:50And we did learn a
  • 41:51bunch of things, and Doug
  • 41:52Hartman, who worked with me
  • 41:54at the time, published this.
  • 41:54What we learned is, number
  • 41:55one, all the pre imaging
  • 41:57stuff is way more important.
  • 41:58How you make the slide,
  • 42:00how is it how quickly
  • 42:01you can dry it before
  • 42:02you can scan it, and
  • 42:03so forth.
  • 42:04That if you if you're
  • 42:05asking pathologists to log into
  • 42:07a digital pathology system, then
  • 42:08a lab information system, then
  • 42:10an AI system, they're gonna
  • 42:11hate you. They just want
  • 42:12one system. So we decided
  • 42:14back into everything needs to
  • 42:15go through the LIS.
  • 42:16We figured out how to
  • 42:17validate people, train people, and
  • 42:20everyone asks us, are you
  • 42:20going FDA? Are you using
  • 42:22FDA? No.
  • 42:24FDA does not regulate us.
  • 42:26The FDA regulates the manufacturer.
  • 42:28And we can choose to
  • 42:29use an FDA
  • 42:30approved or cleared system or
  • 42:32not. In fact, of the
  • 42:34one thousand I or one
  • 42:36thousand plus antibodies we have
  • 42:37in our immunohistochemistry
  • 42:39lab, I I don't think
  • 42:40any of them are FDA
  • 42:41approved for everything we use
  • 42:43them for. They're all off
  • 42:44label.
  • 42:46Plus,
  • 42:47FDA system locks you down.
  • 42:48You cannot change anything. And
  • 42:50even if today I picked
  • 42:51an FDA approved system, I
  • 42:53would not be allowed to
  • 42:53look at any of our
  • 42:54archived images. If I wanna
  • 42:56go look at someone's biopsy
  • 42:57from a year ago, I
  • 42:58would not be allowed to
  • 42:59pull it into the current
  • 43:00FDA system. So it doesn't
  • 43:02really make sense
  • 43:03for our use.
  • 43:05Anyway, we installed these
  • 43:08scanners throughout the lab, and
  • 43:09we learned a lot about
  • 43:10space,
  • 43:11lean flow. The closer your
  • 43:13scanner is to the slide,
  • 43:15the better it is.
  • 43:17We also figured about figured
  • 43:19out about the workflow. Now
  • 43:20many people think that these
  • 43:22image management
  • 43:24systems,
  • 43:25drive the workflow. They're wrong.
  • 43:27An image management system to
  • 43:28me is like an access
  • 43:30database or an Excel spreadsheet.
  • 43:31It manages the images very
  • 43:32well if you're an administrator.
  • 43:34But if you're a pathologist,
  • 43:35no.
  • 43:36You we do not
  • 43:38manage our
  • 43:39cases by slides and blocks.
  • 43:41We manage them by case.
  • 43:43So you really need a
  • 43:44case management system.
  • 43:45Parts, how many, you know,
  • 43:47how many parts are there?
  • 43:47How many slides per part?
  • 43:49How many do need immunos?
  • 43:50How many of those need
  • 43:51an immunosistochemistry
  • 43:52stain. When the stain comes
  • 43:54back, you don't want it
  • 43:55right at the bottom. You
  • 43:56want it back in that
  • 43:57part where it belongs. And
  • 43:59so we worked very hard
  • 44:00with our IT people to
  • 44:02get the workflow to work
  • 44:03out well.
  • 44:05We were also a Copath
  • 44:06user. We're now half an
  • 44:08Epic user. By May ninth,
  • 44:10we'll all be Epic users.
  • 44:11But you can see that
  • 44:13running it through the LIS
  • 44:15makes a whole lot of
  • 44:15sense. And the more we
  • 44:16did this, the more pathologists
  • 44:17accepted it because this was
  • 44:19their workflow. You could look
  • 44:20at this particular case as
  • 44:21part one, part two. I
  • 44:23can see of that part,
  • 44:25three other slides were scanned,
  • 44:26three were not. You can
  • 44:27view one side. You can
  • 44:28view them all. But it's
  • 44:29all through the LIS. You
  • 44:30order a recut. The recut
  • 44:32will get scanned. Come back.
  • 44:33You'll see, oh, it's exactly
  • 44:34in that part. You're in
  • 44:35immuno. You don't have to
  • 44:36go anywhere. You can get
  • 44:37it right done. You need
  • 44:38to now do the report.
  • 44:39You're all in the same
  • 44:40system. So we preferred that
  • 44:41at UPMC.
  • 44:43What we also learned there
  • 44:45is that
  • 44:47currently the way Histo Labs
  • 44:49work is stuff gets assembled,
  • 44:51slides are made, paperworks match,
  • 44:53they get onto flats or
  • 44:54trays, they get delivered to
  • 44:55mailboxes.
  • 44:57And, you know, walk by
  • 44:58and you still have mailboxes
  • 44:59with slides in them. Right?
  • 45:02People felt that going digital,
  • 45:04that all goes away. It's
  • 45:05not true. And we learned
  • 45:07that.
  • 45:08There's still
  • 45:09this kind of work that
  • 45:10needs to be done, administrative
  • 45:11work, but it's in the
  • 45:12digital system. Someone still has
  • 45:14to go in and say,
  • 45:14doctor Desik's on service today.
  • 45:16Next week, she'll be out.
  • 45:17This has to go to
  • 45:18someone else. Someone's gotta go
  • 45:19in and do all that
  • 45:20work and make sure that
  • 45:22the QC gets done.
  • 45:23Now the one thing I
  • 45:25don't agree with the way
  • 45:26some labs that have gone
  • 45:27fully digital are doing their
  • 45:28QC is, how do we
  • 45:30know every image is okay
  • 45:31and every image is in
  • 45:32focus? They're saying, oh, we'll
  • 45:33look at ten images for
  • 45:35each batch. But that sort
  • 45:36of is counter
  • 45:38to automating the whole system.
  • 45:40Now there's AI
  • 45:41that does your QC checks,
  • 45:42and we're testing a few
  • 45:43of those different systems. I
  • 45:45don't really want people to
  • 45:46check that. But what did
  • 45:48change is
  • 45:49the follow just got very
  • 45:50used to
  • 45:51knowing when they had work,
  • 45:52when their mailbox got full,
  • 45:53or someone delivered them stuff,
  • 45:55which is a push system.
  • 45:57What happened when we were
  • 45:58using the omnich system, they
  • 46:00didn't know that their cases
  • 46:01were building up, which is
  • 46:02a pull system. You gotta
  • 46:04go in and you gotta
  • 46:04go log in and see,
  • 46:05see, oh my goodness. I
  • 46:06got thirty five cases, and
  • 46:07it's already eleven o'clock. I
  • 46:08better get started. So that
  • 46:10didn't happen.
  • 46:11And I did learn this.
  • 46:13So I'd asked money for
  • 46:15money to buy the IT
  • 46:16system, buy the hardware, buy
  • 46:17the software.
  • 46:19And they gave me all
  • 46:20these buses.
  • 46:21All these buses arrived and
  • 46:22got lined up, and then
  • 46:24I had no bus drivers.
  • 46:26Okay. Who's gonna scan the
  • 46:27slots?
  • 46:28I'd assume that the hospital
  • 46:29would say, okay. You can
  • 46:30use the histotech time and
  • 46:32or, an admin assistant that
  • 46:34time will train them. We'll
  • 46:35hire you a bunch of
  • 46:36scan tags. No.
  • 46:38If it wasn't budgeted for,
  • 46:41the those were just gonna
  • 46:42sit there and, you know,
  • 46:44and collect dust, which happened
  • 46:46for a while. So I
  • 46:47told them, look. We spent,
  • 46:48you know, seven million dollars.
  • 46:50We do need to, use
  • 46:51the technology.
  • 46:52Okay?
  • 46:53Now I know, having done
  • 46:55that, is you need people.
  • 46:56You need IT analysts. You
  • 46:57need a business analyst. You
  • 46:59need a director of digital
  • 47:00pathology. You need Scantecs.
  • 47:02Otherwise, you're just gonna have
  • 47:03a fleet of buses that
  • 47:04are gonna go nowhere. Okay?
  • 47:08And how do you sign
  • 47:09out? So when you speak
  • 47:10to all the digital pathology
  • 47:11companies, they'll tell you, yeah.
  • 47:13Sign out. It's easy. Look
  • 47:14how we do it in
  • 47:14the electronic system. But that
  • 47:15is not how we sign
  • 47:16out for real. You know
  • 47:18as pathologists.
  • 47:20Sign out,
  • 47:21many times this means we're
  • 47:23looking at the case at
  • 47:24a microscope, either on my
  • 47:26own microscope
  • 47:27or a multi headed microscope
  • 47:28in a conference room, and
  • 47:29then I'm gonna go back
  • 47:30to my office and then
  • 47:32sign out. And, like, digital
  • 47:33pathology vendors are confused. Like,
  • 47:34what are you talking about?
  • 47:36Sign out is when you
  • 47:37sign out the case. No.
  • 47:38Sign out is when you
  • 47:38look at the case, you
  • 47:40figure out how you're gonna
  • 47:40report it, and then you
  • 47:42may electronically sign it out.
  • 47:43So you have to ergonomically
  • 47:45figure out how pathologist offices
  • 47:47are gonna look, where are
  • 47:48these digital pathology monitors gonna
  • 47:50go.
  • 47:51When you're signing out in
  • 47:52a conference room, where's everyone
  • 47:53gonna be, if you wanna
  • 47:55put TVs on the wall.
  • 47:56Well, the aspect, the way
  • 47:57that the image appears is
  • 47:58very different to what it
  • 47:59looks like on the monitor.
  • 48:00And if you you chose
  • 48:01an FDA sys approved system,
  • 48:04putting it up on the
  • 48:05monitor is certainly not part
  • 48:06of the pixel pathway that
  • 48:07the FDA approved, and it
  • 48:08becomes quite complicated. So that's
  • 48:10something you really have to
  • 48:11figure out.
  • 48:12And you've got a lot
  • 48:13of conference rooms around you
  • 48:14and and, you know, ergonomically,
  • 48:16you have to figure that
  • 48:17part out.
  • 48:18But, anyway, we went. We
  • 48:19were scanning away, doing primary
  • 48:21diagnosis with the OmniC system.
  • 48:22And then
  • 48:24the CIO called me and
  • 48:25said, Leron, you're filling up
  • 48:27our servers.
  • 48:29Like, they hadn't planned for
  • 48:31us. He said, I just
  • 48:32look at this.
  • 48:34MRIs, CT scans, PET scans,
  • 48:36they take up hardly any
  • 48:37space, but you guys are
  • 48:39filling up the server at
  • 48:40this enormous rate. Okay? And,
  • 48:42you know, back in the
  • 48:42day, we didn't really think
  • 48:43much about data storage and
  • 48:45how big a whole site
  • 48:45image is, but that's a
  • 48:47big deal. And for most
  • 48:48labs, actually now when they
  • 48:49are budgeting and IT get
  • 48:51wind of how much you
  • 48:52have to pay for data
  • 48:53storage and you want to
  • 48:54back it up as data
  • 48:56recovery,
  • 48:57for disaster recovery,
  • 48:59you have to factor in
  • 49:00that storage is very expensive,
  • 49:01especially if you want to
  • 49:02keep the images.
  • 49:04If you wanna just put
  • 49:05move them to cold storage
  • 49:06on a disk, well, then
  • 49:07it's like a glass slide.
  • 49:08When you request an image,
  • 49:09it'll take days, which makes
  • 49:10no sense.
  • 49:12Now I wish someone had
  • 49:13told me this.
  • 49:15After all the years we
  • 49:16were scanning images, we got
  • 49:18the Omnic system, we got
  • 49:19the Aperio system, we had
  • 49:20a Zeiss system, we had
  • 49:21an Olympus system, a Hamamatsu
  • 49:22system,
  • 49:23and each
  • 49:24vendor had their own proprietary
  • 49:26file format.
  • 49:27And we still had them
  • 49:28all saved. Just the other
  • 49:30day, someone had asked me
  • 49:31for seventy thousand GI polyps
  • 49:33from the Omnic system.
  • 49:35And I said, you can
  • 49:36have them, but they said,
  • 49:37how am I supposed to
  • 49:37view them? I don't have
  • 49:38the viewing software or you
  • 49:40know? So they're not saved
  • 49:41in any standard way. And
  • 49:42so the question is,
  • 49:44should we just do them
  • 49:45by DICOM now going forward?
  • 49:46Because DICOM is a standard.
  • 49:48Radiology adopted that. Should we?
  • 49:49And, yeah, I would say
  • 49:51we could do that.
  • 49:52The problem
  • 49:53is, will every AI vendor
  • 49:54we want be able to
  • 49:55use DICOM? Wanna do image
  • 49:57analysis for ERP or HER2,
  • 49:58they're gonna tell, no. We
  • 49:59don't do it on DICOM
  • 50:00images, etcetera. So the field
  • 50:02has to move forward.
  • 50:04Nevertheless, UPMT has advanced. We
  • 50:07replaced the Omnic system with
  • 50:08the Leica Aperio system.
  • 50:11It's validated for primary diagnosis.
  • 50:13And now we have people
  • 50:14signing up from home. Not
  • 50:15too many.
  • 50:16Here's a perinatal pathologist, doctor
  • 50:18Bob Benden. He lives in
  • 50:19Florida. He's just recently retired.
  • 50:22I brought him out of
  • 50:23retirement to sign out for
  • 50:24placenta cases because we have
  • 50:25so many placentas,
  • 50:27in Pittsburgh. And what actually
  • 50:29happened was at the time,
  • 50:30a lot of politics in
  • 50:31the states around us where
  • 50:32women could not have abortions,
  • 50:33etcetera, they all came to
  • 50:35Pennsylvania,
  • 50:36and I could not cope
  • 50:37with the number of placentas
  • 50:38and POCs that had to
  • 50:39be signed out. And so
  • 50:40Bob said he would. He
  • 50:41wouldn't come back and live
  • 50:42in Pittsburgh. It's too cold.
  • 50:43His wife hated the cold.
  • 50:45So he said he will
  • 50:46sign out. Plus, you can
  • 50:47see there's the the sea
  • 50:49behind him. So in the
  • 50:50morning, he'd wake up, have
  • 50:51breakfast, go for a walk
  • 50:52on the beach, then he'd
  • 50:53come sign out the centers
  • 50:54all day. And our residents
  • 50:56loved him because he took
  • 50:57time and explained it to
  • 50:58them, and they would join
  • 50:59him virtually and they could
  • 51:00send it. So
  • 51:02he told me I have
  • 51:03to pay for his license
  • 51:03in Florida
  • 51:05and Internet access and all
  • 51:06of that. But what we
  • 51:07do have is we have
  • 51:08a team now who can
  • 51:09deploy a workstation. So if
  • 51:10someone wants to work from
  • 51:11home, we take care of
  • 51:12it. We send them a
  • 51:13workstation, get it set up,
  • 51:14barcode monitor. You have to
  • 51:15use our computer.
  • 51:17You have to VPN in
  • 51:18and and you have to
  • 51:19follow all our rules.
  • 51:20And so we have some
  • 51:21pathologists signing out. I even
  • 51:22have a pathologist,
  • 51:24Marta Miniverni, in Italy. She
  • 51:25signed up from home in
  • 51:27Italy,
  • 51:28for extended periods of time.
  • 51:31But
  • 51:32what we did learn
  • 51:34is
  • 51:35I again opened another Pandora's
  • 51:37box because a lot of
  • 51:38senior pathologists asked me, hey,
  • 51:39Lauren. I was gonna retire.
  • 51:41Can I go part time
  • 51:42and work from home? And
  • 51:44I didn't want a whole
  • 51:46department working from home because
  • 51:47there are downsides to that.
  • 51:49But also, if people do
  • 51:51work from home,
  • 51:52they do help us cover
  • 51:53the service, cost coverage, etcetera.
  • 51:55And so I found that
  • 51:56the most
  • 51:58popular phenotype of pathologists who
  • 52:00asked me to sign up
  • 52:01from home are
  • 52:03either those who are
  • 52:04one to five years in
  • 52:05practice
  • 52:06because
  • 52:07hard to find care, especially
  • 52:09if two people are working
  • 52:10and then there's no one
  • 52:11taking care of the kids.
  • 52:13I was joking with doctor.
  • 52:14So, Nad, if
  • 52:16If you're signing out from
  • 52:16home and taking care of
  • 52:17the kids, like, are you
  • 52:18sure the kids aren't all
  • 52:19over your computer workstation?
  • 52:23I've never asked that question.
  • 52:26So people who want to
  • 52:27retire and people who have
  • 52:29childcare needs
  • 52:30or other needs work from
  • 52:31home. And I have so
  • 52:32far, I have about six
  • 52:34five or six people.
  • 52:36The the sixth one is
  • 52:37because when she's in Italy,
  • 52:38she signed up, but when
  • 52:39she's back, she comes into
  • 52:40work.
  • 52:42But I don't want the
  • 52:43whole department to work from
  • 52:44home. As you know, that's
  • 52:45not the best thing.
  • 52:47So we learned a whole
  • 52:48lot of,
  • 52:50stuff about
  • 52:51going to primary diagnosis.
  • 52:53If you are not married
  • 52:54to your vendor and you
  • 52:55don't like your vendor, you're
  • 52:56in big trouble. This is
  • 52:57a bad marriage because there's
  • 52:59a lot of things that
  • 53:00have to happen. If your
  • 53:01pathologists are not willing to
  • 53:03do this, it's gonna be
  • 53:04an uphill battle.
  • 53:06I would suggest you don't
  • 53:07do it as a big
  • 53:07bang and do it right
  • 53:08away. What we have found
  • 53:10is if you pick
  • 53:12areas where small pieces of
  • 53:14tissue like pediatric pathology,
  • 53:17autopsy service, and then work
  • 53:18your way up.
  • 53:19I'll tell you a funny
  • 53:20story that a colleague of
  • 53:21mine decided, Dara, I'm not
  • 53:22doing it your way. I'm
  • 53:22not doing it incrementally. It's
  • 53:24just too painful, especially if
  • 53:25you have a hybrid system,
  • 53:26half glass,
  • 53:27half digital, just so difficult
  • 53:29for the lab. We're going
  • 53:30fully digital. And then one
  • 53:31of his pathologists said, I'm
  • 53:33quitting because I'm not doing
  • 53:34it. And the reason was
  • 53:35because
  • 53:37he couldn't see the images.
  • 53:38He didn't know he needed
  • 53:40glasses because he could
  • 53:41he could focus with his
  • 53:43microscope, sadly, but not on
  • 53:44a computer monitor.
  • 53:46And so once they figured
  • 53:47that out, he didn't quit
  • 53:48and, you know, it was
  • 53:49okay.
  • 53:51Alright.
  • 53:52Now not every slide in
  • 53:53the world can be scanned.
  • 53:56These are slides people asked
  • 53:57me to scan, old AFIP
  • 53:59slide, broken slide, double cover
  • 54:01slip, etcetera. You know, the
  • 54:02scanner will not scan everything
  • 54:03around, so you will still
  • 54:03need a microscope around somewhere.
  • 54:03And this garbage in, garbage
  • 54:03out principle is
  • 54:09important, as I told you.
  • 54:09Everyone
  • 54:11needs to know. Your resident
  • 54:12set of grossing, your surge
  • 54:13techs, peers need to know
  • 54:14that whatever I'm cutting this
  • 54:16piece of tissue, putting in
  • 54:17a in a cassette is
  • 54:19ultimately gonna be scanned and
  • 54:20be on someone's computer monitor.
  • 54:22So everyone needs to be
  • 54:23mindful. So, for example,
  • 54:25if you have all of
  • 54:26these pieces of tissue,
  • 54:28completely fills the block, when
  • 54:30they open the cassette and
  • 54:31it's about to explode, that's
  • 54:32gonna go all over the
  • 54:33slide. You don't want
  • 54:35that. When your histo technologists
  • 54:36are arranging stuff, for example,
  • 54:38you don't want them to
  • 54:38put tissue all over the
  • 54:39place. You want it really
  • 54:41well arranged, close together because
  • 54:43if it's close together, it's
  • 54:44easy to scan. You're not
  • 54:45scanning all this white space,
  • 54:47storing it. When someone's looking
  • 54:49at it on a monitor,
  • 54:50you don't want, you know,
  • 54:51them to get carpal tunnel
  • 54:52at the end of the
  • 54:52month. You know, you want
  • 54:54it to be easy.
  • 54:56I finally convinced our geopathologists
  • 54:57that they need ribbons and
  • 54:59ribbons and ribbons of everything
  • 55:00on, you know, slide after
  • 55:02slide after slide. Even our
  • 55:03geopathologists.
  • 55:04Less slides, less ribbons,
  • 55:06and they agree it actually
  • 55:08saves a lot of histotech
  • 55:09time.
  • 55:11Even
  • 55:12our histo lab now have
  • 55:14pristine slides, pristine barcodes,
  • 55:16no fingerprints,
  • 55:17no mounting media. That all
  • 55:19impacts the quality of the
  • 55:20image.
  • 55:21And I proved that to
  • 55:22myself. If if if you
  • 55:23cannot focus, can you imagine
  • 55:25what an image algorithm is
  • 55:26gonna look, try and deal
  • 55:27with it? So this was,
  • 55:30an image analysis algorithm to,
  • 55:32you know, quantify HER2. You
  • 55:33could see the green is
  • 55:34HER2 one, then there's HER2,
  • 55:36and HER3 is the red.
  • 55:38And the more multimedia and
  • 55:39blurry it is, I can
  • 55:41make any HER2
  • 55:42zero.
  • 55:43If it's blurry, the algorithm
  • 55:44will make it zero for
  • 55:45you. And how would you
  • 55:46know?
  • 55:48But do not be OCD
  • 55:49about it. Right? That's it.
  • 55:51Minor artifacts don't matter, which
  • 55:53I've told our pathologists.
  • 55:55Hey. Yeah.
  • 55:56A fingerprint there, it's not
  • 55:57the end of the world.
  • 55:58You can see that you're
  • 55:59dealing with a leiomyosarcoma
  • 56:01because there's a hair under
  • 56:02the coverslip. You know, you
  • 56:03cannot refuse to sign out
  • 56:04the case. Right?
  • 56:07But there are some things
  • 56:08that are a big deal.
  • 56:08This is a core needle
  • 56:09biopsy of a of a
  • 56:11breast biopsy.
  • 56:12This has got invasive dachal
  • 56:14carcinoma. It went for HER2
  • 56:15staining. And you don't see
  • 56:17the HER2. It's a HER2
  • 56:18zero case, basically.
  • 56:20But the
  • 56:21the image algorithm came back
  • 56:23as three plus because it
  • 56:24counted those bubbles under the
  • 56:26coverslip
  • 56:27slip as membranous staining. And
  • 56:27if a human never checked,
  • 56:29well, then it would be
  • 56:30a mistake.
  • 56:32So the next thing we
  • 56:33did is open up an
  • 56:34image analysis lab where we
  • 56:35do quantitative image analysis. It's
  • 56:37as simple as as Facebook
  • 56:39does,
  • 56:40classify the things in the
  • 56:41image, detect them, segment them
  • 56:42out, count the features.
  • 56:44How much staining, what's intensity,
  • 56:46etcetera. And so we do
  • 56:48that now. But we have
  • 56:50changed, and our image analysis
  • 56:51lab runs like a CP
  • 56:53medicine lab. We do Levy
  • 56:55Jennings parts. We check for
  • 56:56the CV. Is there drift
  • 56:58in the algorithm? Is there
  • 56:59drift in the immunostain?
  • 57:01Yeah. I took two algorithms
  • 57:02that were running and just
  • 57:04ran them on the same
  • 57:04twenty cases, and they were
  • 57:06completely different for the ER
  • 57:07and KR sixty seven. People
  • 57:09would assume that, oh, the
  • 57:10computer is always right. Well,
  • 57:11it's not always right unless
  • 57:13you monitor it.
  • 57:15We've now moved into computational
  • 57:17pathology. There's a fancy definition
  • 57:19for computational pathology, but it's
  • 57:21really AI mostly applied to
  • 57:22pathology.
  • 57:23And you can see in
  • 57:24PubMed,
  • 57:25there are thousands and thousands
  • 57:27of articles
  • 57:28about computational pathology. So if
  • 57:30you're asking when should we
  • 57:31do AI,
  • 57:32that train has left that
  • 57:34station long ago. You should
  • 57:35have already been doing AI.
  • 57:37Okay.
  • 57:38So we asked
  • 57:40AI, what would a pathologist's
  • 57:41life be like using AI?
  • 57:43And this is what it
  • 57:43said. That was the only
  • 57:45prompt.
  • 57:48Looks like some of the
  • 57:48offices in our hospital still
  • 57:50are like that. I'm not
  • 57:51gonna blame you.
  • 57:53But in a digitally well
  • 57:55organized world, you know, obviously,
  • 57:56we could be much better.
  • 57:58And you can use AI
  • 57:58for anything you want.
  • 58:00Go detect rare things like
  • 58:01bugs,
  • 58:03count mitoses,
  • 58:04make diagnosis of cancer, make
  • 58:05predictions, or use it for
  • 58:07research.
  • 58:08I got tired of screening
  • 58:09AFB stains myself,
  • 58:11and I never trusted the
  • 58:12residents. The fellow said, Yeah,
  • 58:13there's nothing there. Then I
  • 58:14would look with them, and
  • 58:14in one minute I'll find
  • 58:15a mycobacterium.
  • 58:17So we built our own
  • 58:18AFIB screening
  • 58:20algorithm. It's been running now
  • 58:21for many years,
  • 58:22and it detects the AFB.
  • 58:24It's much more accurate and
  • 58:25quicker.
  • 58:27Now there are three types
  • 58:29of pathologists.
  • 58:30There are those who use
  • 58:32this only. They don't want
  • 58:33the slide anymore.
  • 58:34There are those that wait
  • 58:35for the slide. They trust
  • 58:37the issue. They want to
  • 58:37check themselves. And there are
  • 58:39those that do not use
  • 58:40this at all. Only wait
  • 58:41for the slide. And so
  • 58:43when I asked some of
  • 58:44those pathologists, why do you
  • 58:45not trust and use the
  • 58:47AI? And you know what
  • 58:48the main reason was?
  • 58:49This.
  • 58:53It's not integrated.
  • 58:55If you're gonna use something,
  • 58:56you want it nice and
  • 58:57integrated and easy to use.
  • 58:58They do not want it.
  • 58:59They got an email notification.
  • 59:01AFV is ready for your
  • 59:02case, this case number. Now
  • 59:03they gotta go log in
  • 59:04to Copath,
  • 59:05get into the case. It
  • 59:06said, if it was all
  • 59:07integrated,
  • 59:08they would use it more
  • 59:09often.
  • 59:12When we we installed our
  • 59:13first AI algorithm about six
  • 59:14years ago, it was IBEX
  • 59:16for prostate cancer.
  • 59:18I asked the CAP, and
  • 59:19I was on the CAP
  • 59:20committee and many others, how
  • 59:21do how do we validate
  • 59:22this? We knew about whole
  • 59:23site imaging, but how do
  • 59:24we validate
  • 59:25AI? How many cases? What
  • 59:27are we checking for? What
  • 59:27are parameters?
  • 59:28They did not know. No
  • 59:30one actually
  • 59:31could give me advice.
  • 59:33But what I did know
  • 59:34is that I'm not gonna
  • 59:35do analytical validation like a
  • 59:36vendor does. You know? Build
  • 59:38the algorithm, hold out a
  • 59:40whole bunch of stuff. That's
  • 59:41like building a car. I
  • 59:42don't want that.
  • 59:43I know that I cannot
  • 59:44use technical verification.
  • 59:46That's like going to a
  • 59:47car dealership and the the
  • 59:49car salesman showing you all
  • 59:50the features and, yeah, we'll
  • 59:51calibrate it and tweak it.
  • 59:53No. That's no good. I
  • 59:54need to test drive it
  • 59:56so that I know it
  • 59:57works.
  • 59:58And how many cases? I
  • 59:59don't know. So what we
  • 01:00:00did, just so that you
  • 01:00:01know so for prostate, I
  • 01:00:03took three thousand slides,
  • 01:00:06turned about so hundred cases
  • 01:00:07with three thousand slides,
  • 01:00:10scanned them,
  • 01:00:11had them all analyzed by
  • 01:00:13AI,
  • 01:00:14and then we had,
  • 01:00:15compared it to the pathologist
  • 01:00:16diagnosis. And there were three
  • 01:00:18zero discrepancies.
  • 01:00:19Cancer and no cancer, grading
  • 01:00:21differences, perineural invasion or not.
  • 01:00:23And the pathologist at the
  • 01:00:24time told me that, you
  • 01:00:25see, AI is not right
  • 01:00:26all the time. But the
  • 01:00:27truth is all three of
  • 01:00:28those cases were correct. The
  • 01:00:30AI was correct. We adjudicated
  • 01:00:31that by, you know, consensus,
  • 01:00:33another expert, and immunohistochemistry.
  • 01:00:36And here's an example where
  • 01:00:37the pathologist originally felt this
  • 01:00:39was negative. AI thought it
  • 01:00:40was three plus three, and
  • 01:00:41the AI was correct based
  • 01:00:43on immunohistochemistry
  • 01:00:44staining. And the xAI means
  • 01:00:46explainable AI. Our pathologists really
  • 01:00:47want to see what's going
  • 01:00:48on with the AI. So
  • 01:00:49by overlaying a heat map
  • 01:00:51makes the AI explainable. There's
  • 01:00:53the cancer. The red means
  • 01:00:54it's we think it's malignant,
  • 01:00:56etcetera.
  • 01:00:58How do you install AI?
  • 01:00:59That's a different issue. Do
  • 01:01:01you do it upfront? Do
  • 01:01:02you do it later? Initially,
  • 01:01:04for example, the pathologist
  • 01:01:05said, do it once we've
  • 01:01:06done the case just as
  • 01:01:08a quality check, but but
  • 01:01:09they soon realized that that
  • 01:01:10makes no sense. So much
  • 01:01:12more efficient upfront. So now,
  • 01:01:13for example, our GU group,
  • 01:01:14by the time they get
  • 01:01:15there in the morning, everything
  • 01:01:16scanned, run by AI, preliminary
  • 01:01:19report generated.
  • 01:01:20Even the fellow is way
  • 01:01:21more efficient, so their service
  • 01:01:22is much more efficient.
  • 01:01:24But how we use AI
  • 01:01:25is different, and so because
  • 01:01:27the hospital did ask me
  • 01:01:29this. At the academic hospitals,
  • 01:01:31my academic pathologists are a
  • 01:01:33little insulted if I tell
  • 01:01:34them that it's to check
  • 01:01:35check accuracy because many of
  • 01:01:36them tell me, Lauren, you
  • 01:01:37know, people send me consults,
  • 01:01:38etcetera. You know, I don't
  • 01:01:40need that checked. What they
  • 01:01:41really want is the efficiency.
  • 01:01:43Save time so they can
  • 01:01:44have time to write papers,
  • 01:01:45do admin
  • 01:01:46academic work. Whereas in the
  • 01:01:48community, and we have many
  • 01:01:50community hospitals, they do wanna
  • 01:01:51know that they didn't over
  • 01:01:53or under call anything. So
  • 01:01:54it's the exact same algorithm.
  • 01:01:55They're much more happier having
  • 01:01:57AI check everything. And, actually,
  • 01:01:59I'm happy that these general
  • 01:02:00pathologists are not overwhelming our
  • 01:02:02academic pathologists with all these
  • 01:02:04cases. You know, prostate with
  • 01:02:05ASAP,
  • 01:02:06you can handle it on
  • 01:02:07your own. You do not
  • 01:02:08have to send it to
  • 01:02:09a subspecialist.
  • 01:02:10But a lot of questions
  • 01:02:11have come up over time.
  • 01:02:12You're on which apps are
  • 01:02:13you using? How are you
  • 01:02:15deciding only if it's FDA
  • 01:02:16or if other people are
  • 01:02:17using it? How are you
  • 01:02:18paying for it? Should the
  • 01:02:19residents and fellows use it
  • 01:02:20or not, etcetera?
  • 01:02:22And you will learn all
  • 01:02:23of those over time.
  • 01:02:25But I do feel that
  • 01:02:27we should be doing more
  • 01:02:28with AI. You know, not
  • 01:02:29just having AI do exactly
  • 01:02:30what pathologists do, same grading,
  • 01:02:32WHO,
  • 01:02:33Bethesda. We should really be
  • 01:02:35looking into a crystal ball
  • 01:02:37and making advances.
  • 01:02:38And so that's where we
  • 01:02:39should go. But
  • 01:02:40I decided I cannot do
  • 01:02:42this on my own, so
  • 01:02:43I created a computational pathology
  • 01:02:44and informatics division. Doctor Hooman
  • 01:02:46Rasheedi, who trained here at
  • 01:02:47Yale now, he runs that.
  • 01:02:50Matthew Uhanna is the vice
  • 01:02:51chair of informatics, helps with
  • 01:02:53all of this process.
  • 01:02:55And Ibrahim,
  • 01:02:56a recurant, runs the image
  • 01:02:57analysis lab.
  • 01:02:58And they're all competent.
  • 01:03:01I open up an AI
  • 01:03:02center now called our computational
  • 01:03:03pathology and AI center.
  • 01:03:05They build AI. They validate
  • 01:03:07AI. And I I they
  • 01:03:08don't like it, but I
  • 01:03:09tell them they're my oil
  • 01:03:10refinery.
  • 01:03:11They take all the crew
  • 01:03:12data from lab medicine,
  • 01:03:15seat,
  • 01:03:15and as well as images,
  • 01:03:17and then make whatever jet
  • 01:03:18fuel I need. I need
  • 01:03:19them to do this. I
  • 01:03:20need them to do that,
  • 01:03:21and they do that,
  • 01:03:22along with an academic mission.
  • 01:03:25The one thing I found
  • 01:03:26over time is it's very
  • 01:03:27hard to work with vendors.
  • 01:03:28I used to vendors would
  • 01:03:29say, no. We have a
  • 01:03:30new scanner. We have a
  • 01:03:31new system. Can you test
  • 01:03:32it for us? But I
  • 01:03:33had all these rules in
  • 01:03:34our hospital. Ninety days,
  • 01:03:37supply chain management won't allow
  • 01:03:38this, and so I decided
  • 01:03:40I'm not going through that
  • 01:03:41process anymore. So I opened
  • 01:03:42up a digital pathology research
  • 01:03:43center.
  • 01:03:44I called it research. So
  • 01:03:45it's under research. Hospital have
  • 01:03:47no sort of,
  • 01:03:49you
  • 01:03:50know,
  • 01:03:51say in how long anything
  • 01:03:52stays or which vendor comes.
  • 01:03:54You know, we make sure
  • 01:03:55we have ethical clearance. We
  • 01:03:56have compliance, IRBs.
  • 01:03:58I had so many
  • 01:04:00companies come to me, digital
  • 01:04:02pathology, AI,
  • 01:04:03and even novel imaging companies,
  • 01:04:05Muse and others.
  • 01:04:06I had to open up
  • 01:04:07an office of collaborative pathology.
  • 01:04:09I have a medical director
  • 01:04:10who runs that. I have
  • 01:04:11a lawyer now, an administrator.
  • 01:04:12I have a compliance officer.
  • 01:04:14I have a PhD scientist
  • 01:04:16who checks the scope of
  • 01:04:17work. And so we've already
  • 01:04:18done forty projects,
  • 01:04:20multimillion dollar
  • 01:04:22operation, and that money all
  • 01:04:23comes into the department.
  • 01:04:25Okay? And And everyone loves
  • 01:04:26it because they get access
  • 01:04:27to technology. If we like
  • 01:04:29it, we'll translate it and
  • 01:04:31move it over into the
  • 01:04:32clinical operation.
  • 01:04:34And lastly, what we've realized
  • 01:04:35at UPMC is that I've
  • 01:04:37had algorithms that we've built
  • 01:04:38ourselves, but they only work
  • 01:04:39at UPMC. Like that acid
  • 01:04:41fast bacillus algorithm. I've had
  • 01:04:43a pathologist send me and
  • 01:04:44ask me if we would
  • 01:04:45run it, run her images
  • 01:04:46for us.
  • 01:04:48She wanted to quantify them
  • 01:04:49for her research project. And
  • 01:04:50we ran them, and we
  • 01:04:51couldn't find the AFB.
  • 01:04:53So just because we build
  • 01:04:55it doesn't mean it's generalizable.
  • 01:04:56So we have decided that
  • 01:04:58we are building a consortium
  • 01:05:00which
  • 01:05:01is underway.
  • 01:05:02We are working with partners
  • 01:05:03around the U. S. Globally,
  • 01:05:05people from Chile, Mexico,
  • 01:05:08Japan,
  • 01:05:10Tata Memorial Cancer Center, etcetera,
  • 01:05:12who are all providing us
  • 01:05:13with data so that we
  • 01:05:14can build much better AI
  • 01:05:15algorithms that can generalize for
  • 01:05:17everyone and also meet all
  • 01:05:19their priorities.
  • 01:05:20So at the end of
  • 01:05:20the day, that's the message
  • 01:05:22I tell everyone I work
  • 01:05:22with.
  • 01:05:24I'm not replacing them
  • 01:05:25yet,
  • 01:05:27but I'm just giving them
  • 01:05:28the tools to make their
  • 01:05:29job easier. Right? Whether it's
  • 01:05:31screening Pap tests or whether
  • 01:05:32it's looking at corneal lobsters
  • 01:05:34of breasts, prostate, etcetera. So
  • 01:05:36I'll leave you with this
  • 01:05:36final quote from Darwin.
  • 01:05:38It's not the strongest of
  • 01:05:39the species that survives nor
  • 01:05:41the most intelligent,
  • 01:05:42but it's the one that
  • 01:05:43is most adaptable to change.
  • 01:05:45So you have to be,
  • 01:05:46you know, willing to change.
  • 01:05:47So sorry if I went
  • 01:05:48over for a little bit,
  • 01:05:49but thank you for your
  • 01:05:50attention.
  • 01:05:55Doctor Daisig, is there time
  • 01:05:56for questions or no? No?
  • 01:05:58We have time for questions.
  • 01:06:00Oh, okay.
  • 01:06:03Any questions?
  • 01:06:05First
  • 01:06:09question.
  • 01:06:21So when kids go and
  • 01:06:23get their car license today,
  • 01:06:24do we make them go
  • 01:06:25with shift stick or automatic?
  • 01:06:27When kids get their car
  • 01:06:29licenses today, are we gonna
  • 01:06:30make them all go with
  • 01:06:31a shift stick so that
  • 01:06:32just in case they have
  • 01:06:33today, you're gonna use a
  • 01:06:34shift stick, or is it
  • 01:06:35okay to get your car
  • 01:06:36license with an automatic vehicle?
  • 01:06:38For me. The entire transmission
  • 01:06:40of the solar system is
  • 01:06:41still keeping That's right. So
  • 01:06:43and I did this experiment.
  • 01:06:44So our GU fellow was
  • 01:06:45not allowed to our GU
  • 01:06:47fellow was not allowed to
  • 01:06:47use AI
  • 01:06:49each year. But when I
  • 01:06:50got there as the chair,
  • 01:06:51I told him it makes
  • 01:06:52no sense.
  • 01:06:53Actually, what we're doing is,
  • 01:06:55because they were saying we
  • 01:06:55would deskill the the GEO
  • 01:06:57fellow like you're saying. They
  • 01:06:58would not be able to
  • 01:06:59be as good as previous
  • 01:07:00fellows to find the cancer
  • 01:07:01and actually grade it themselves.
  • 01:07:04And I told them, actually,
  • 01:07:04what we're doing is, we
  • 01:07:06are deskilling them to go
  • 01:07:07practice in the future because,
  • 01:07:09they would who's gonna train
  • 01:07:11them to do AI, especially
  • 01:07:12if we have AI around?
  • 01:07:13We need to upscale them.
  • 01:07:15And so I had a
  • 01:07:16fellow who had done six
  • 01:07:17months of his fellowship, GU
  • 01:07:18fellow. And then I asked
  • 01:07:19him, would he be willing
  • 01:07:20to switch halfway through? And
  • 01:07:22we'd actually document everything he'd
  • 01:07:24done. So we documented everything
  • 01:07:25he'd done for six months,
  • 01:07:27his diagnoses compared to, you
  • 01:07:28know, it's, the ones that
  • 01:07:30sign out, how efficient he
  • 01:07:31was, how efficient the service
  • 01:07:33ran, etcetera. And And then
  • 01:07:34we switched, and we documented
  • 01:07:35everything. And so what had
  • 01:07:37happened was, firstly, the service
  • 01:07:38was way more efficient. Okay?
  • 01:07:40Everyone could sign out by
  • 01:07:41eight eight or nine AM
  • 01:07:43in the morning. Everything was
  • 01:07:44done, screened. All the cases
  • 01:07:46that needed immunos were already
  • 01:07:47sent off. They came back
  • 01:07:48the same day because they
  • 01:07:49met the cutoff.
  • 01:07:50Okay.
  • 01:07:53The fellow
  • 01:07:54got much better. Okay. Because
  • 01:07:57the fellow looked at the
  • 01:07:57case and then turned on,
  • 01:07:58you know, the heat heat
  • 01:07:59maps afterwards. He didn't wanna
  • 01:08:00ruin his ability not to
  • 01:08:02be able to try and
  • 01:08:02make diagnoses.
  • 01:08:05And then guess what happened
  • 01:08:06every time there was an
  • 01:08:07issue, technical
  • 01:08:09AI, whatever?
  • 01:08:10Who do you think the
  • 01:08:11champion was that they went
  • 01:08:12to? All the attendings. The
  • 01:08:13fellow.
  • 01:08:15The fellow was so good
  • 01:08:16that they asked me to
  • 01:08:17hire him. He's now faculty.
  • 01:08:18He's been on faculty for
  • 01:08:19two years. Okay? And he's
  • 01:08:20still the AI champion.
  • 01:08:21And now he does GU
  • 01:08:23research.
  • 01:08:24And guess what he uses
  • 01:08:25to do his GU research?
  • 01:08:27He doesn't lean over a
  • 01:08:28microscope doing it. He uses
  • 01:08:29the AI to do all
  • 01:08:31different things, spatial
  • 01:08:32biology and different things.
  • 01:08:34It's a completely new microscope
  • 01:08:36for him. And so
  • 01:08:38I would say, I think
  • 01:08:39it would be detrimental if
  • 01:08:41you have the tools and
  • 01:08:41technology not to let the
  • 01:08:43people use it. I'm not
  • 01:08:44gonna force people to use
  • 01:08:45a shift stick because that's
  • 01:08:46just how everyone used to
  • 01:08:47do it. So that's my
  • 01:08:49opinion.
  • 01:08:50Okay.
  • 01:09:30So the answer is no
  • 01:09:31to both your questions. I
  • 01:09:32have not tracked people's,
  • 01:09:34RBUs. I tracked them for,
  • 01:09:37quality purposes or when to
  • 01:09:39hire, but not for personal
  • 01:09:40productivity. But now that you've
  • 01:09:41told me, yeah, I think
  • 01:09:42I'm gonna do that.
  • 01:09:44I think it's hard because
  • 01:09:45probably that will be Yeah.
  • 01:09:47At some level. Yeah. So
  • 01:09:49I think I'm gonna do
  • 01:09:49that. The groups that use
  • 01:09:50AI, and a good time
  • 01:09:52so, you know, we're we're
  • 01:09:53now doing all the PAP
  • 01:09:55tests with the Genius AI
  • 01:09:56system. So, it will be
  • 01:09:58a good thing to monitor
  • 01:09:59actually that we have,
  • 01:10:02twelve side of pathologists that
  • 01:10:03do PAPs. That's how I
  • 01:10:04wanna monitor actually the RVUs
  • 01:10:06before, RVUs now, see if
  • 01:10:07they're quicker. The problem is
  • 01:10:09I I'm reluctant to share
  • 01:10:10that data because, you know,
  • 01:10:11the administrators will tell me
  • 01:10:13that,
  • 01:10:14you know, we see that
  • 01:10:15your pataras are going home
  • 01:10:16now at four o'clock as
  • 01:10:17opposed to six or seven
  • 01:10:18o'clock. And so, you know,
  • 01:10:21and so maybe we should
  • 01:10:22hire less, etcetera. So that's
  • 01:10:23the the one thing. And
  • 01:10:24then in terms of
  • 01:10:25people being compensated to work
  • 01:10:27from home, no. It's the
  • 01:10:28same. I mean, people have
  • 01:10:29raised the point that, well,
  • 01:10:30you know, they don't pay
  • 01:10:31for parking and things like
  • 01:10:32that, which is true. But
  • 01:10:35we have not changed compensation,
  • 01:10:37for people that work from
  • 01:10:38home. Oh, you mentioned I
  • 01:10:39think I heard it. Just
  • 01:10:40double check. So you do
  • 01:10:42pay
  • 01:10:45No. I told him not
  • 01:10:46Internet access. So he asked
  • 01:10:48for Internet access. I said
  • 01:10:49I would pay for his
  • 01:10:50license, for him to maintain
  • 01:10:52CME. I'd pay for all
  • 01:10:53the equipment,
  • 01:10:54but I'm not paying for
  • 01:10:55his Netflix Internet access. Yeah.
  • 01:11:02Yeah. Because otherwise, he's gonna
  • 01:11:03want fiber optic and everything.
  • 01:11:05Yeah.
  • 01:11:06Alright. Any other questions?
  • 01:11:08Well, if anyone has you
  • 01:11:09have a question? Uh-huh.
  • 01:11:11Oh, yeah.
  • 01:11:12Without any reimbursement for the
  • 01:11:13new technology,
  • 01:11:16are we
  • 01:11:17foresee maintaining this
  • 01:11:19and figure it financially
  • 01:11:21viable?
  • 01:11:24Yeah. So that's a million
  • 01:11:25dollar question,
  • 01:11:26and I cannot just answer
  • 01:11:27it in a few minutes.
  • 01:11:29But,
  • 01:11:32there there are many ways
  • 01:11:33you can, provide that answer.
  • 01:11:35First, they are digital they
  • 01:11:36are CPT codes for digital
  • 01:11:37pathology. There are thirteen CPT
  • 01:11:39codes. They're tracking codes for
  • 01:11:41now.
  • 01:11:41Trying to get your LIS
  • 01:11:42system to do that is
  • 01:11:43not easy. So if you
  • 01:11:45track those CPT codes, you
  • 01:11:47can show,
  • 01:11:48your administrators
  • 01:11:50how much you digitize and
  • 01:11:51the value it brings.
  • 01:11:53Two is,
  • 01:11:55there's the quality workload factor.
  • 01:11:58So
  • 01:11:59I would, for example, have
  • 01:12:00to send out all those
  • 01:12:02perinatal placenta cases,
  • 01:12:04and we've had to, you
  • 01:12:06know, use that number, which
  • 01:12:07is a huge number, actually,
  • 01:12:10even for perinatal autopsies. For
  • 01:12:11someone to do a phytopsy,
  • 01:12:13that's a four thousand dollar
  • 01:12:14charge for us.
  • 01:12:16So you, you know, you
  • 01:12:17can factor that in. I've
  • 01:12:18also shown them how much
  • 01:12:20it costs to archive. Because
  • 01:12:21when you archive and you
  • 01:12:22request a case from the
  • 01:12:23archive, you have to pay
  • 01:12:24for that. So there are
  • 01:12:26many, many things you can
  • 01:12:27do that builds up. There
  • 01:12:28isn't one
  • 01:12:29ROU
  • 01:12:30ROI. You need many different
  • 01:12:32things to build up an
  • 01:12:33ROI. But the and and
  • 01:12:34I've done all of that
  • 01:12:35and explained it to our
  • 01:12:36institution because I'm asking them
  • 01:12:38to ramp up our digital
  • 01:12:39pathology operation. But at the
  • 01:12:40end of the day, they
  • 01:12:41always ask the same question
  • 01:12:42is, well, how many
  • 01:12:44fewer doctors can you hire
  • 01:12:46through the system? And I've
  • 01:12:47told them the computers are
  • 01:12:48not yet to replace the
  • 01:12:49doctors.
  • 01:12:51And I've told them that
  • 01:12:52it's the same when in
  • 01:12:54two thousand and ten, when
  • 01:12:54we barcoded our lab, they
  • 01:12:56also asked me and Anil
  • 01:12:57Purwani back then, why are
  • 01:12:59we paying for this? Where's
  • 01:13:00the return on investment?
  • 01:13:02Like, where does the barcoding
  • 01:13:04make money? It made no
  • 01:13:05sense to them, to the
  • 01:13:06CFOs and the accountants.
  • 01:13:10And all we could tell
  • 01:13:11them was that, well, this
  • 01:13:12makes us
  • 01:13:13better,
  • 01:13:14safer.
  • 01:13:15You know, we're avoiding mistakes.
  • 01:13:17We're avoiding, you know, mix
  • 01:13:18ups of,
  • 01:13:20cases.
  • 01:13:21We are saving potentially millions
  • 01:13:23in lawsuits, and it was
  • 01:13:24all potential cost savings. But,
  • 01:13:26eventually, they allowed us to
  • 01:13:27do it. And now can
  • 01:13:28you imagine if they did
  • 01:13:29not agree to pay for
  • 01:13:31that infrastructure?
  • 01:13:32But I think they realize
  • 01:13:34that
  • 01:13:35if you don't go digital,
  • 01:13:36you cannot do AI. And
  • 01:13:37everyone's doing AI now, not
  • 01:13:39just pathology. Our cardiologists are
  • 01:13:41using AI. Even our neurosurgeons
  • 01:13:43are using AI to guide
  • 01:13:44them,
  • 01:13:45when they're doing surgery. Our
  • 01:13:46radiologists have, like, seventeen AI
  • 01:13:48algorithms running. So we're actually
  • 01:13:50behind. We have six AI
  • 01:13:52algorithms. We are behind other
  • 01:13:53departments. So they realize that
  • 01:13:55we will not be able
  • 01:13:56to even catch up with
  • 01:13:57radiology, cardiology, some of the
  • 01:13:59surgeries
  • 01:14:00if they don't allow us
  • 01:14:01to go digital.
  • 01:14:03And they know that for
  • 01:14:04a hospital of forty and
  • 01:14:05now we're gonna be forty
  • 01:14:06five hospitals, there's no way
  • 01:14:08I can efficiently run that
  • 01:14:09system. What they really want
  • 01:14:11me to do is consolidate.
  • 01:14:12They do not want forty
  • 01:14:13five histology labs. But if
  • 01:14:15I can have four or
  • 01:14:16five histology labs throughout a
  • 01:14:18whole region,
  • 01:14:20that saves the system a
  • 01:14:21whole lot of money. So
  • 01:14:23they've understood that message. It's
  • 01:14:25hard to tell that story,
  • 01:14:26but you have to tell
  • 01:14:27that story. Hopefully, that answers
  • 01:14:30some of the things we've
  • 01:14:30done.
  • 01:14:32So if anyone else has
  • 01:14:33questions, you can just ask
  • 01:14:34doctor Daisy for my email.
  • 01:14:37She'll screen it first, and
  • 01:14:38then you can, she'll send
  • 01:14:39it on to me.
  • 01:14:42Okay. Thanks for your time.